[go: up one dir, main page]

EP3149110B1 - Liquid crystal medium - Google Patents

Liquid crystal medium Download PDF

Info

Publication number
EP3149110B1
EP3149110B1 EP15723433.7A EP15723433A EP3149110B1 EP 3149110 B1 EP3149110 B1 EP 3149110B1 EP 15723433 A EP15723433 A EP 15723433A EP 3149110 B1 EP3149110 B1 EP 3149110B1
Authority
EP
European Patent Office
Prior art keywords
compounds
liquid
denotes
alkyl
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15723433.7A
Other languages
German (de)
French (fr)
Other versions
EP3149110A1 (en
Inventor
Martin Engel
Harald Hirschmann
Ingo ALMEROTH
Timo Uebel
Rocco Fortte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of EP3149110A1 publication Critical patent/EP3149110A1/en
Application granted granted Critical
Publication of EP3149110B1 publication Critical patent/EP3149110B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3477Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a five-membered aromatic ring containing at least one nitrogen atom
    • C09K19/348Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a five-membered aromatic ring containing at least one nitrogen atom containing at least two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/0403Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems
    • C09K2019/0411Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems containing a chlorofluoro-benzene, e.g. 2-chloro-3-fluoro-phenylene-1,4-diyl
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/123Ph-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3004Cy-Cy
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3009Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/301Cy-Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3016Cy-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3027Compounds comprising 1,4-cyclohexylene and 2,3-difluoro-1,4-phenylene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3028Cyclohexane rings in which at least two rings are linked by a carbon chain containing carbon to carbon single bonds
    • C09K2019/3036Cy-C2H4-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3066Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers
    • C09K19/3068Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers chain containing -COO- or -OCO- groups
    • C09K2019/3075Cy-COO-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3066Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers
    • C09K19/3068Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers chain containing -COO- or -OCO- groups
    • C09K2019/3077Cy-Cy-COO-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring

Definitions

  • Such media are to be used in particular for electro-optical displays with an active-matrix addressing based on the ECB effect as well as for in-plane switching or Fringe Field Switching (FFS) displays.
  • FFS Fringe Field Switching
  • VAN V ertically A capitad N Ematic
  • MVA M Ultimatum D omain V ertical A lignment
  • FK phases are needed, which must meet a variety of requirements. Particularly important here are the chemical resistance to moisture, air and physical influences such as heat, radiation in the infrared, visible and ultraviolet range and electrical alternating and alternating fields.
  • LC phases require a liquid-crystalline mesophase in a suitable temperature range and a low viscosity.
  • Matrix liquid crystal displays are known.
  • active elements ie transistors
  • Type 1 typically uses dynamic scattering or guest-host effect as the electro-optic effect.
  • the use of monocrystalline silicon as a substrate material limits the display size, since the modular composition of various partial displays on the joints leads to problems.
  • the TN effect is usually used as the electro-optical effect.
  • TFTs made of compound semiconductors, such as e.g. CdSe or TFTs based on polycrystalline or amorphous silicon.
  • CdSe compound semiconductors
  • TFTs based on polycrystalline or amorphous silicon The latter technology is being worked on worldwide with great intensity.
  • the TFT matrix is applied on the inside of one glass plate of the display, while the other glass plate on the inside carries the transparent counter electrode. Compared to the size of the pixel electrode, the TFT is very small and practically does not disturb the image.
  • This technology can also be extended to fully color-capable image representations, wherein a mosaic of red, green and blue filters is arranged such that each one filter element is opposite to a switchable image element.
  • Such MFK displays are particularly suitable for TV applications (eg pocket TV) or for high-information displays in automotive or aircraft.
  • difficulties arise in the case of MFK displays due to the insufficiently high specific resistance of the liquid-crystal mixtures [ TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, Sept. 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, p.
  • the drawback of the commonly used MFK TN displays is their relatively low contrast, the relatively high viewing angle dependence, and the difficulty in creating grayscale in these displays.
  • VA displays Significantly better viewing angle dependencies are found on VA displays and are therefore mainly used for TVs and monitors.
  • frame rates frame rate / repetition rates
  • the characteristics, such as the low-temperature stability, must not be impaired.
  • the invention is based on the object liquid crystal mixtures, such as known from DE 10 2012 004871 A1 . WO 2006/002747 A1 . DE 10 2004 012970 A1 . DE10 2011 013007 . EP 2 722 380 A2 and WO 200/017180 A1 in particular for monitor and TV applications which are based on the ECB or on the IPS or FFS effect to provide, which have the disadvantages mentioned above, or only to a lesser extent.
  • it must be ensured for monitors and TVs that they operate at extremely high and extremely low temperatures and at the same time have very low switching times and at the same time have an improved reliability behavior, in particular no or significantly reduced image sticking after long runtimes.
  • decomposition may occur within the liquid crystal mixture. Under UV exposure, a large decrease in Voltage Holding Ratio (VHR) is often observed.
  • VHR Voltage Holding Ratio
  • Object of the present invention is therefore to provide liquid crystal mixtures that cause no or no significant problems at elevated temperatures and under UV exposure.
  • the invention thus relates to a liquid-crystalline medium according to claim 1, which contains the compound of formula I-1 and / or the compound of formula I-2.
  • the mixtures according to the invention are both stable at elevated temperatures and under UV exposure, preferably show very broad nematic phase ranges with clearing points ⁇ 70 ° C, preferably ⁇ 75 ° C, in particular ⁇ 80 ° C, very favorable values for the capacitive threshold, relative high values for the holding ratio and at the same time very good low-temperature stabilities at -20 ° C and -30 ° C as well as very low Rotational viscosities and low switching times.
  • the mixtures according to the invention are further distinguished by the fact that, in addition to the improvement of the rotational viscosity ⁇ 1 , relatively high values of the elastic constants K 33 can be observed to improve the switching times.
  • either the compound of the formula I-1 or the compound of the formula I-2 is added to the liquid-crystalline mixture.
  • the compound I-1 or I-2 is used in amounts of 50-10,000 ppm, in particular 100-6,000 ppm and very particularly preferably 300-4,000 ppm, based on the liquid-crystalline mixture. If the liquid-crystal mixture contains the compounds I-1 and I-2, the two compounds may be added in equal amounts or in different amounts. However, the total concentration should not exceed 6000 - 10000 ppm based on the mixture.
  • the compounds of formulas I-1 and I-2 are commercially available, e.g. B. from the company Sigma-Aldrich.
  • Z 2 may have the same or different meanings.
  • Z 2 and Z 2 ' may have the same or different meanings.
  • Z 2 and Z 2 ' in the formulas IIA and IIB preferably each independently a single bond, further a -C 2 H 4 - or a -CH 2 O bridge.
  • Z 2 -C 2 H 4 - or -CH 2 O-
  • (O) C v H 2v + 1 preferably denotes OC v H 2v + 1 , furthermore C v H 2v + 1 .
  • (O) C v H 2v + 1 is preferably C v H 2v + 1 .
  • L 3 and L 4 are preferably in each case F.
  • alkyl and alkyl * each independently represent a straight-chain alkyl radical having 1-6 C atoms.
  • Particularly preferred mixtures according to the invention contain one or more compounds of the formulas IIA-2, IIA-8, IIA-14, IIA-26, II-28, IIA-33, IIA-39, IIA-45, IIA-46, IIA-47 , IIA-50, IIB-2, IIB-11, IIB-16 and IIC-1.
  • the proportion of compounds of the formulas IIA and / or IIB in the total mixture is preferably at least 20% by weight.
  • Preferred media contain one or more compounds of formulas O-1, O-3, O-4, O-6, O-7, O-10, O-11, O-12, O-14, O-15, O -16 and / or 0-17.
  • mixtures according to the invention containing the compounds of the formula O-10, O-12, O-16 and / or O-17, in particular in amounts of 5-30%.
  • the medium according to the invention particularly preferably contains the trinuclear compounds of the formula O-10a and / or of the formula O-10b in combination with one or more dinuclear compounds of the formulas O-17a to O-17d.
  • the total amount of the compounds of formula O-10a and / or O-10b in combination with one or more compounds selected from the binuclear compounds of the formulas O-17a to O-17d 5-40%, most preferably 15-35%.
  • Very particularly preferred mixtures contain the compounds O-10a and O-17a:
  • the compounds O-10a and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and particularly preferably 18-22%, based on the total mixture.
  • Very particularly preferred mixtures contain the compounds O-10b and O-17a:
  • the compounds O-10b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and particularly preferably 18-22%, based on the total mixture.
  • Very particularly preferred mixtures contain the following three compounds:
  • the compounds O-10a, O-10b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and particularly preferably 18-22%, based on the total mixture.
  • Preferred mixtures contain at least one compound selected from the group of compounds wherein R 1 and R 2 have the meanings given above.
  • R 1 preferably denotes alkyl or alkenyl having 1-6 or 2-6 C atoms and R 2 alkenyl having 2-6 C atoms.
  • the mixtures according to the invention preferably contain the compounds of the formulas BC, CR, PH-1, PH-2 and / or BF in amounts of from 3 to 20% by weight, in particular in amounts of from 3 to 15% by weight.
  • the compounds of the formulas L-1 to L-11 are preferably used in concentrations of 5 to 50% by weight, in particular 5 to 40% by weight and very particularly preferably 10 to 40% by weight.
  • Another object of the invention is an electro-optical display with an active matrix addressing based on the ECB, VA, PS-VA, PA-VA, IPS, PS-IPS, FFS, UB-FFS or PS -FFS effect, characterized in that it contains as a dielectric liquid-crystalline medium according to one or more of claims 1 to 15.
  • the liquid-crystalline medium according to the invention preferably has a nematic phase of ⁇ -20 ° C to ⁇ 70 ° C, more preferably from ⁇ -30 ° C to ⁇ 80 ° C, most preferably from ⁇ -40 ° C to ⁇ 90 ° C ,
  • the term "having a nematic phase" on the one hand means that no smectic phase and no crystallization is observed at low temperatures at the corresponding temperature and, on the other hand, that no clarification occurs during heating from the nematic phase.
  • the investigation at low temperatures is carried out in a flow viscometer at the appropriate temperature and by storage in test cells corresponding to the electro-optical application Layer thickness checked for at least 100 hours.
  • the storage stability at a temperature of -20 ° C in a corresponding test cell is 1,000 hours or more, the medium is said to be stable at this temperature.
  • the corresponding times are 500 h or 250 h.
  • the clearing point is measured in capillaries by conventional methods.
  • the liquid-crystal mixture preferably has a nematic phase range of at least 60 K and a flow viscosity v 20 of at most 30 mm 2 ⁇ s -1 at 20 ° C.
  • the values of the birefringence ⁇ n in the liquid-crystal mixture are generally between 0.07 and 0.16, preferably between 0.08 and 0.13.
  • the liquid-crystal mixture according to the invention has a ⁇ of -0.5 to -8.0, in particular of -2.5 to -6.0, where ⁇ denotes the dielectric anisotropy.
  • the rotational viscosity ⁇ 1 at 20 ° C is preferably ⁇ 150 mPa ⁇ s, especially ⁇ 120 mPa ⁇ s.
  • the liquid-crystal media according to the invention have relatively small values for the threshold voltage (Vo). Preferably, they are in the range of 1.7V to 3.0V, more preferably ⁇ 2.5V, and most preferably ⁇ 2.3V.
  • threshold voltage for the present invention refers to the capacitive threshold (V 0 ), also called Freedericksz threshold, unless explicitly stated otherwise.
  • liquid-crystal media according to the invention have high values for the voltage holding ratio in liquid-crystal cells.
  • liquid crystal media with a low drive voltage or threshold voltage show a lower voltage holding ratio than those with a larger drive voltage or threshold voltage and vice versa.
  • dielectrically positive compounds mean those compounds with a ⁇ > 1.5, "dielectrically neutral compounds” those with -1.5 ⁇ ⁇ ⁇ 1.5 and “dielectrically negative” compounds those with ⁇ ⁇ - 1.5.
  • the dielectric anisotropy of the compounds is determined by 10% of the compounds are dissolved in a liquid crystalline host and the capacity of the resulting mixture in at least one test cell with 20 micron layer thickness is determined with homeotropic and homogeneous surface orientation at 1 kHz.
  • the measurement voltage is typically 0.5 V to 1.0 V, but it is always lower than the capacitive threshold of the liquid crystal mixture under investigation.
  • the mixtures according to the invention are suitable for all VA-TFT applications, such as, for example, VAN, MVA, (S) -PVA, ASV, PSA (polymer-sustained VA) and PS-VA (polymer-stabilized VA). Furthermore, they are for IPS (I n p lane s witching) and FFS (F rings f ield s witching), preferably UB-FFS, with a negative ⁇ suitable.
  • the nematic liquid-crystal mixtures in the displays according to the invention generally contain two components A and B, which in turn consist of one or more individual compounds.
  • the component A has a markedly negative dielectric anisotropy and gives the nematic phase a dielectric anisotropy of ⁇ -0.5. It preferably contains, in addition to one or more compounds of the formulas IIA, IIB and / or IIC, furthermore one or more compounds of the formula 0-17.
  • the proportion of component A is preferably between 45 and 100%, in particular between 60 and 100%.
  • one (or more) individual compound (s) is preferably selected which have a value of ⁇ ⁇ -0.8. This value must be the more negative the smaller the proportion A of the total mixture is.
  • the component B has a pronounced nematogeneity and a flow viscosity of not more than 30 mm 2 .s -1 , preferably not more than 25 mm 2 .s -1 , at 20 ° C.
  • Particularly preferred individual compounds of component B are extremely low-viscosity nematic liquid crystals having a flow viscosity of not more than 18, preferably not more than 12 mm 2 ⁇ s 1 , at 20 ° C.
  • Component B is monotropic or enantiotropic nematic, has no smectic phases and can prevent the occurrence of smectic phases in liquid crystal mixtures up to very low temperatures. If, for example, a smectic liquid-crystal mixture is mixed with in each case different materials with high nematogeneity, the degree of suppression of smectic phases achieved can be used to compare the nematogeneity of these materials.
  • the mixture may also contain a component C, which are compounds having a dielectric anisotropy of ⁇ ⁇ 1.5.
  • component C which are compounds having a dielectric anisotropy of ⁇ ⁇ 1.5.
  • positive compounds are generally contained in a mixture with negative dielectric anisotropy in amounts of ⁇ 20% by weight, based on the total mixture.
  • the compounds of the formulas P-1 to P-4 are preferably used in concentrations of 2 to 15%, in particular 2 to 10%, in the mixtures according to the invention.
  • the compound of the formula which is preferably used in amounts of 2-15% in the mixtures according to the invention.
  • these liquid crystal phases may also contain more than 18 components, preferably 18 to 25 components.
  • the phases preferably contain 4 to 15, in particular 5 to 12, and particularly preferably ⁇ 10, compounds of the formulas IIA, IIB and / or IIC and optionally one or more compounds the formula O-17.
  • the other constituents are preferably selected from the nematic or nematogenic substances, in particular the known substances, from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, cyclohexane-carboxylic acid phenyl or cyclohexyl esters, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes , 1,4-bis-cyclohexylbiphenyls or cyclohexylpyrimidines, phenyl- or cyclohexyldioxanes, optionally halogenated stilbenes, benzylphenyl ethers, tolans and substituted cinnamic acid esters.
  • R 20 and R 21 are different from each other, one of these radicals is usually an alkyl or alkoxy group.
  • Other variants of the proposed substituents are in use. Many such substances or mixtures thereof are commercially available. All these substances can be prepared by literature methods.
  • VA, PALC, PS-VA, IPS, PS-IPS, FFS or PS-FFS mixture according to the invention can also contain compounds in which, for example, H, N, O, Cl, F are replaced by the corresponding isotopes.
  • the mixtures according to the invention may furthermore contain polymerizable compounds, so-called reactive mesogens (RMs), for example in US 6,861,107 disclosed, in concentrations of preferably 0.01 to 5 wt.%, Particularly preferably 0.2 to 2% based on the mixture added.
  • these mixtures may also contain an initiator such as described in US 6,781,665.
  • the initiator for example Irganox-1076 from BASF, is preferably added to the mixture containing polymerizable compounds in amounts of 0-1%.
  • Such mixtures can be used for so-called polymer stabilized VA modes (PS-VA) or PSA (polymer sustained VA), in which a polymerization of the reactive mesogens in the liquid-crystalline mixture is to take place.
  • PS-VA polymer stabilized VA modes
  • PSA polymer sustained VA
  • the polymerization is preferably carried out under the following conditions:
  • the polymerizable reactive mesogen (s) (RM) is (are) polymerized in a cell using a UV-A lamp of defined intensity for a defined period of time and applied voltage (typically 10V to 30V Alternating voltage, frequencies in the range of 60 Hz to 1 kHz).
  • the UV-A light source used is typically a metal halide lamp or a high-pressure mercury lamp with an intensity of 50 mW / cm 2.
  • liquid crystalline compounds having an alkenyl or Alkenlyoxychannelkette such as. B. the compound of the formula do not polymerize.
  • the mixtures according to the invention may further contain conventional additives or additives, e.g. Stabilizers, antioxidants, UV absorbers, nanoparticles, microparticles, etc.
  • additives or additives e.g. Stabilizers, antioxidants, UV absorbers, nanoparticles, microparticles, etc.
  • the structure of the liquid crystal displays according to the invention corresponds to the usual geometry, as for example in EP-OS 0 240 379 , is described.
  • 1,4-cyclohexylene rings and 1,4-phenylene rings are represented as follows:
  • the cyclohexylene rings are trans-1,4-cyclohexylene rings.
  • the mixtures according to the invention preferably contain, in addition to the compounds of the formula I-1 and / or I-2, one or more compounds of the following compounds from Table A.
  • Table A ⁇ / u> ⁇ /b>
  • the following abbreviations are used: (n, m, m ', z: each independently 1, 2, 3, 4, 5 or 6; (O) C m H 2m + 1 means OC m H 2m + 1 or C m H 2m + 1 )
  • the preparation of the liquid crystal mixtures which can be used according to the invention is carried out in a conventional manner.
  • the desired amount of the components used in lesser amount is dissolved in the constituent of the main component, expediently at elevated temperature.
  • solutions of the components in an organic solvent e.g. in acetone, chloroform or methanol, and to remove the solvent again after thorough mixing, for example by distillation.
  • liquid crystal phases according to the invention can be modified such that they can be used in any type of z.
  • B. ECB, VAN, IPS, GH or ASM-VA LCD display can be used.
  • the dielectrics may also other, known in the art and described in the literature additives such.
  • UV absorbers antioxidants, nanoparticles, radical scavengers included.
  • 0-15% pleochroic dyes, stabilizers or chiral dopants may be added.
  • Suitable stabilizers for the mixtures according to the invention are in particular those listed in Table B.
  • pleochroic dyes may be added, further conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf., for example Haller et al., Mol. Cryst. Liq. Cryst. Volume 24, pages 249-258 (1973 )) to improve conductivity or substances for changing the dielectric anisotropy, the viscosity and / or the orientation of the nematic phases.
  • Such substances are z. Tie DE-OS 22 09 127 . 22 40 864 . 23 21 632 . 23 38 281 . 24 50 088 . 26 37 430 and 28 53 728 described.
  • Table B lists possible dopants which can be added to the mixtures according to the invention. If the mixtures contain a dopant, it is used in amounts of 0.01-4% by weight, preferably 0.1-1.0% by weight. ⁇ b> ⁇ u> Table B ⁇ / u> ⁇ /b> In Table B possible dopants are given, which are usually added to the mixtures of the invention. Preferably, the mixtures contain 0-10 wt.%, In particular 0.01-5 wt.% And particularly preferably 0.01-3 wt.% Of dopants. Stabilizers which can be added, for example, to the mixtures according to the invention in amounts of 0-10% by weight are mentioned below.
  • an initiator or a mixture of two or more initiators must be added for the polymerization. The initiator or the initiator mixture is preferably added in amounts of 0.001-2% by weight, based on the mixture. A suitable initiator is z.
  • BASF Irgacure
  • BASF Irganox
  • the mixtures according to the invention comprise one or more polymerizable compounds, preferably selected from the polymerizable compounds of the formulas RM-1 to RM-98.
  • Such media are particularly suitable for PS-FFS and PS-IPS applications.
  • the compounds RM-1, RM-2, RM-3, RM-4, RM-5, RM-11, RM-17, RM-35, RM-41, RM- 44, RM-62 and RM-81 are particularly preferred.
  • temperatures such as the melting point T (C, N), the transition from the smectic (S) to the nematic (N) phase T (S, N) and the clearing point T (N, I), in degrees Celsius (° C).
  • Mp means melting point
  • bp clearing point.
  • K crystalline state
  • N nematic phase
  • S smectic phase
  • I isotropic phase. The information between these symbols represents the transition temperatures.
  • the sales mixture ZLI-4792 (from Merck KGaA) is used. used.
  • the sales mixture ZLI-2857 is used for the determination of the dielectric anisotropy ⁇ . From the change in the dielectric constant of the host mixture after addition of the test compound and extrapolation to 100% of the compound used, the physical data of the compound to be tested are obtained. Depending on the solubility, the compound to be tested is usually dissolved at 10% in the host mixture.
  • low temperature stability also referred to as “LTS” (low temperature stability), i. the stability of the LC mixture against spontaneous crystallization of individual components at low temperatures
  • vials are stored with 1 ml FK / RM mixture at Temperaturren between 0 ° C and -30 ° C and it is checked regularly whether the mixtures were crystallized.
  • the VHR value is measured as follows: The FK-host mixture is optionally filled with the compound of the formula I-1 and / or I-2 and the resulting mixture in TN-VHR test cells (90 ° rubbed, orientation layer TN Polyimide (eg SE 2414 Nissan Chemicals, or AL-16301, JSR, layer thickness d ⁇ 6 ⁇ m)
  • the HR value is measured either at room temperature (RT) or after 5 min at 100 ° C before and after 0.5 h or 2 h UV exposure (suntest) at 1 V, 60 Hz, 64 ⁇ s pulse determined (measuring device: Autronic-Melcher's VHRM-105).
  • HTP helical twisting power
  • CY-3-O2 12.00% Clearing point [° C]: 86.5 CY-3-O4 2.00% ⁇ n [589 nm, 20 ° C]: .1092 CY-5-O2 12.00% ⁇ [1 kHz, 20 ° C]: -4.2 CCY-3-O1 6.00% ⁇ ⁇ [1 kHz, 20 ° C]: 3.7 CCY-3-O2 8.00% K 3 [pN, 20 ° C]: 16.6 CCY-4-O2 8.00% K 3 / K 1 [20 ° C]: 1.14 CPY-2-O2 9.00% ⁇ 1 [mPa.s, 20 ° C]: 155 CPY-3-O2 9.00% LTS bulk (-30 ° C): > 1000 h PYP 2-3 5.00% CC-3-V1 5.00% CC-3-V 19.00% BCH-32 5.00%
  • CY-3-O2 12.00% Clearing point [° C]: 86.5 CY-3-O4 2.00% ⁇ n [589 nm, 20 ° C]: .1092 CY-5-O2 12.00% ⁇ [1 kHz, 20 ° C]: -4.2 CCY-3-O1 6.00% ⁇ ⁇ [1 kHz, 20 ° C]: 3.7 CCY-3-O2 8.00% K 3 [pN, 20 ° C]: 16.6 CCY-4-O2 8.00% K 3 / K 1 [20 ° C]: 1.14 CPY-2-O2 9.00% ⁇ 1 [mPa.s, 20 ° C]: 155 CPY-3-O2 9.00% LTS bulk (-30 ° C): > 1000 h PYP 2-3 5.00% CC-3-V1 5.00% CC-3-V 19.00% BCH-32 5.00%

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal Substances (AREA)

Description

Die Erfindung betrifft ein flüssigkristallines Medium nach Anspruch 1, welches die Verbindung der Formel I-1 und/oder die Verbindung der Formel I-2

Figure imgb0001
enthält,
und
zusätzlich eine oder mehrere Verbindungen ausgewählt aus der Gruppe der Verbindungen der Formeln IIA, IIB und IIC,
Figure imgb0002
Figure imgb0003
Figure imgb0004
worin

R2A, R2B und R2C
jeweils unabhängig voneinander H, einen unsubstituierten, einen einfach durch CN oder CF3 oder mindestens einfach durch Halogen substituierten Alkyl- oder Alkenylrest mit bis zu 15 C-Atomen, wobei in diesen Resten auch eine oder mehrere CH2-Gruppen durch -O-, -S-,
Figure imgb0005
-C≡C-, -CF2O-, -OCF2-, -OC-O- oder -O-CO- so ersetzt sein können, dass O-Atome nicht direkt miteinander verknüpft sind,
L1-4
jeweils unabhängig voneinander F, Cl, CF3 oder CHF2,
Z2 und Z2'
jeweils unabhängig voneinander Einfachbindung, -C≡C-, -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -COO-, -OCO-, -C2F4-, -CF=CF-, -CH=CHCH2O-,
p
0, 1 oder 2,
q
0 oder 1, und
v
1 bis 6
bedeuten,
enthält.The invention relates to a liquid-crystalline medium according to claim 1, which is the compound of formula I-1 and / or the compound of formula I-2
Figure imgb0001
contains
and
additionally one or more compounds selected from the group of the compounds of the formulas IIA, IIB and IIC,
Figure imgb0002
Figure imgb0003
Figure imgb0004
wherein
R 2A , R 2B and R 2C
in each case independently of one another H, an unsubstituted alkyl or alkenyl radical having up to 15 carbon atoms which is monosubstituted by CN or CF 3 or at least monosubstituted by halogen, where one or more CH 2 groups in these radicals are also represented by -O-, -S-,
Figure imgb0005
-C≡C, -CF 2 O-, -OCF 2 -, -OC-O- or -O-CO- may be replaced so that O atoms are not directly linked to one another,
L 1-4
each independently of one another F, Cl, CF 3 or CHF 2 ,
Z 2 and Z 2 '
each independently of one another single bond, -C≡C-, -CH 2 CH 2 -, -CH = CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -C 2 F 4 -, -CF = CF-, -CH = CHCH 2 O-,
p
0, 1 or 2,
q
0 or 1, and
v
1 to 6
mean,
contains.

Derartige Medien sind insbesondere für elektrooptische Anzeigen mit einer Aktivmatrix-Adressierung basierend auf dem ECB-Effekt sowie für IPS-Anzeigen (In plane switching) oder FFS-Anzeigen (Fringe Field Switching) zu verwenden.Such media are to be used in particular for electro-optical displays with an active-matrix addressing based on the ECB effect as well as for in-plane switching or Fringe Field Switching (FFS) displays.

Das Prinzip der elektrisch kontrollierten Doppelbrechung, der ECB-Effekt (electrically controlled birefringence) oder auch DAP-Effekt (Deformation aufgerichteter Phasen) wurde erstmals 1971 beschrieben ( M.F. Schieckel und K. Fahrenschon, "Deformation of nematic liquid crystals with vertical orientation in electrical fields", Appl. Phys. Lett. 19 (1971), 3912 ). Es folgten Arbeiten von J.F. Kahn (Appl. Phys. Lett. 20 (1972), 1193 ) und G. Labrunie und J. Robert (J. Appl. Phys. 44 (1973), 4869 ).The principle of electrically controlled birefringence, the ECB effect (electrically controlled birefringence) or the DAP effect (deformation of upright phases) was first described in 1971 ( MF Schieckel and K. Fahrenschon, "Deformation of nematic liquid crystals with vertical orientation in electrical fields", Appl. Phys. Lett. 19 (1971), 3912 ). It followed Works by JF Kahn (Appl Phys Physic Lett 20 (1972), 1193 ) and G. Labrunie and J. Robert (J. Appl. Phys. 44 (1973), 4869 ).

Die Arbeiten von J. Robert und F. Clerc (SID 80 Digest Techn. Papers (1980), 30), J. Duchene (Displays 7 (1986), 3) und H. Schad (SID 82 Digest Techn. Papers (1982), 244) haben gezeigt, dass flüssigkristalline Phasen hohe Werte für das Verhältnis der elastischen Konstanten K3/K1, hohe Werte für die optische Anisotropie Δn und Werte für die dielektrische Anisotropie von Δε ≤ -0,5 aufweisen müssen, um für hochinformative Anzeigeelemente basierend auf dem ECB-Effekt eingesetzt werden zu können. Auf dem ECB-Effekt basierende elektrooptische Anzeigeelemente weisen eine homeotrope Randorientierung auf (VA-Technologie = Vertical Aligned). Auch bei Anzeigen, die den sogenannten IPS- oder FFS-Effekt verwenden, können dielektrisch negative Flüssigkristallmedien zum Einsatz kommen.The work of J. Robert and F. Clerc (SID 80 Digest Techn. Papers (1980), 30), J. Duchene (Displays 7 (1986), 3) and H. Schad (SID 82 Digest Techn. Papers (1982). , 244) have shown that liquid-crystalline phases must have high values for the ratio of the elastic constants K 3 / K 1 , high values for the optical anisotropy Δn and values for the dielectric anisotropy of Δε ≦ -0.5 in order to obtain highly informative display elements based on the ECB effect. On the ECB effect based electro-optical display elements have a homeotropic edge alignment (VA technology = V ertical A ligned). Even displays that use the so-called IPS or FFS effect, dielectric-negative liquid-crystal media can be used.

Anzeigen, die den ECB-Effekt verwenden, haben sich als sogenannte VAN- (Vertically Aligned Nematic) Anzeigen beispielsweise in den Bauformen MVA (Multi-Domain Vertical Alignment, z.B.: Yoshide, H. et al., Vortrag 3.1: "MVA LCD for Notebook or Mobile PCs ...", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Buch I, S. 6 bis 9 und Liu, C.T. et al., Vortrag 15.1: "A 46-inch TFT-LCD HDTV Technnology ...", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Buch II, S. 750 bis 753 ), PVA (Patterned Vertical Alignment, z.B.: Kim, Sang Soo, Vortrag 15.4: "Super PVA Sets New State-of-the-Art for LCD-TV", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Buch II, S. 760 bis 763 ), ASV- (Advanced Super View, z.B.: Shigeta, Mitzuhiro und Fukuoka, Hirofumi, Vortrag 15.2: "Development of High Quality LCDTV", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Buch II, S. 754 bis 757 ) Anzeigen, neben IPS (In Plane Switching) (z.B.: Yeo, S.D., Vortrag 15.3: "A LC Display for the TV Application", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Buch II, S. 758 & 759 ) den lange bekannten TN- (Twisted Nematic) Anzeigen, als eine der drei zur Zeit wichtigsten neueren Typen von Flüssigkristallanzeigen, insbesondere für Fernsehanwendungen, etabliert. In allgemeiner Form werden die Technologien z.B. in Souk, Jun, SIDSeminar 2004, Seminar M-6: "Recent Advances in LCD Technology", Seminar Lecture Notes, M-6/1 bis M-6/26 und Miller, lan, SIDSeminar 2004, Seminar M-7: "LCD-Television", Seminar Lecture Notes, M-7/1 bis M-7/32 , verglichen. Obwohl die Schaltzeiten moderner ECB-Anzeigen durch Ansteuerungsmethoden mit Übersteuerung (overdrive) bereits deutlich verbessert wurden, z.B.: Kim, Hyeon Kyeong et al., Vortrag 9.1: "A 57-in. Wide UXGA TFT-LCD for HDTV Application", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Buch I, S. 106 bis 109 , ist die Erzielung von videotauglichen Schaltzeiten, insbesondere beim Schalten von Graustufen, immer noch ein noch nicht zufriedenstellend gelöstes Problem.Displays using the ECB effect, have proved to be so-called VAN (V ertically A ligned N Ematic) See, for example, in the MVA (M Ultimatum D omain V ertical A lignment, including: Yoshide, H. et al., Lecture 3.1: "MVA LCD for Notebook or Mobile PCs ...", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book I, pp. 6-9 and Liu, CT et al., Lecture 15.1: "A 46-inch TFT-LCD HDTV Technology ...", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 750-753 ), PVA (Patterned Vertical Alignment, eg: Kim, Sang Soo, Lecture 15.4: "Super PVA Sets New State-of-the-Art for LCD TV", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 760-763 ), ASV (Advanced Super View, eg: Shigeta, Mitzuhiro and Fukuoka, Hirofumi, Lecture 15.2: "Development of High Quality LCDTV", SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 754-757 ) Displays, besides IPS ( I n P lane S witching) (eg: Yeo, SD, Lecture 15.3: "A LC Display for the TV Application," SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 758 & 759 ) The long-known TN (T Wisted N Ematic) displays, as one of the top three at the time newer types of liquid crystal displays, in particular for television applications, established. In general terms, the technologies are eg in Souk, Jun, SIDSeminar 2004, Seminar M-6: "Recent Advances in LCD Technology", Seminar Lecture Notes, M-6/1 to M-6/26 and Miller, lan, SIDSeminar 2004, Seminar M-7: "LCD Television", Seminar Lecture Notes, M-7/1 to M-7/32 , compared. Although the switching times of modern ECB displays have already been significantly improved by overdrive control methods, eg: Kim, Hyeon Kyeong et al., Lecture 9.1: "A 57-in. Wide UXGA TFT-LCD for HDTV Application," SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book I, pp. 106-109 , the achievement of videotauglichen switching times, especially when switching grayscale, still a not yet satisfactorily solved problem.

Für die technische Anwendung dieses Effektes in elektrooptischen Anzeigeelementen werden FK-Phasen benötigt, die einer Vielzahl von Anforderungen genügen müssen. Besonders wichtig sind hier die chemische Beständigkeit gegenüber Feuchtigkeit, Luft und physikalischen Einflüssen wie Wärme, Strahlung im infraroten, sichtbaren und ultravioletten Bereich und elektrische Gleich- und Wechselfelder.For the technical application of this effect in electro-optical display elements FK phases are needed, which must meet a variety of requirements. Particularly important here are the chemical resistance to moisture, air and physical influences such as heat, radiation in the infrared, visible and ultraviolet range and electrical alternating and alternating fields.

Ferner wird von technisch verwendbaren FK-Phasen eine flüssigkristalline Mesophase in einem geeigneten Temperaturbereich und eine niedrige Viskosität gefordert.Furthermore, technically usable LC phases require a liquid-crystalline mesophase in a suitable temperature range and a low viscosity.

In keiner der bisher bekannten Reihen von Verbindungen mit flüssigkristalliner Mesophase gibt es eine Einzelverbindung, die allen diesen Erfordernissen entspricht. Es werden daher in der Regel Mischungen von zwei bis 25, vorzugsweise drei bis 18, Verbindungen hergestellt, um als FK-Phasen verwendbare Substanzen zu erhalten. Optimale Phasen konnten jedoch auf diese Weise nicht leicht hergestellt werden, da bisher keine Flüssigkristallmaterialien mit deutlich negativer dielektrischer Anisotropie und ausreichender Langzeitstabilität zur Verfügung standen.In none of the previously known series of compounds with liquid-crystalline mesophase there is a single compound that meets all these requirements. As a rule, mixtures of two to 25, preferably three to 18, compounds are therefore prepared in order to obtain substances which can be used as LC phases. However, optimal phases could not easily be produced in this way since no liquid crystal materials with clearly negative dielectric anisotropy and sufficient long-term stability were available to date.

Matrix-Flüssigkristallanzeigen (MFK-Anzeigen) sind bekannt. Als nichtlineare Elemente zur individuellen Schaltung der einzelnen Bildpunkte können beispielsweise aktive Elemente (d.h. Transistoren) verwendet werden.Matrix liquid crystal displays (MFK displays) are known. As non-linear elements for individual switching of the individual pixels, for example, active elements (ie transistors) can be used.

Man spricht dann von einer "aktiven Matrix", wobei man zwei Typen unterscheiden kann:

  1. 1. MOS (Metal Oxide Semiconductor)-Transistoren auf Silizium-Wafer als Substrat.
  2. 2. Dünnfilm-Transistoren (TFT) auf einer Glasplatte als Substrat.
One speaks then of an "active matrix", whereby one can distinguish two types:
  1. 1. MOS (Metal Oxide Semiconductor) transistors on silicon wafer as a substrate.
  2. 2. Thin-film transistors (TFT) on a glass plate as a substrate.

Bei Typ 1 wird als elektrooptischer Effekt üblicherweise die dynamische Streuung oder der Guest-Host-Effekt verwendet. Die Verwendung von einkristallinem Silizium als Substratmaterial beschränkt die Displaygröße, da auch die modulartige Zusammensetzung verschiedener Teildisplays an den Stößen zu Problemen führt.Type 1 typically uses dynamic scattering or guest-host effect as the electro-optic effect. The use of monocrystalline silicon as a substrate material limits the display size, since the modular composition of various partial displays on the joints leads to problems.

Bei dem aussichtsreicheren Typ 2, welcher bevorzugt ist, wird als elektrooptischer Effekt üblicherweise der TN-Effekt verwendet.In the more promising type 2, which is preferred, the TN effect is usually used as the electro-optical effect.

Man unterscheidet zwei Technologien: TFT's aus Verbindungshalbleitern wie z.B. CdSe oder TFT's auf der Basis von polykristallinem oder amorphem Silizium. An letzterer Technologie wird weltweit mit großer Intensität gearbeitet.A distinction is made between two technologies: TFTs made of compound semiconductors, such as e.g. CdSe or TFTs based on polycrystalline or amorphous silicon. The latter technology is being worked on worldwide with great intensity.

Die TFT-Matrix ist auf der Innenseite der einen Glasplatte der Anzeige aufgebracht, während die andere Glasplatte auf der Innenseite die transparente Gegenelektrode trägt. Im Vergleich zu der Größe der Bildpunkt-Elektrode ist der TFT sehr klein und stört das Bild praktisch nicht. Diese Technologie kann auch für voll farbtaugliche Bilddarstellungen erweitert werden, wobei ein Mosaik von roten, grünen und blauen Filtern derart angeordnet ist, dass je ein Filterelement einem schaltbaren Bildelement gegenüber liegt.The TFT matrix is applied on the inside of one glass plate of the display, while the other glass plate on the inside carries the transparent counter electrode. Compared to the size of the pixel electrode, the TFT is very small and practically does not disturb the image. This technology can also be extended to fully color-capable image representations, wherein a mosaic of red, green and blue filters is arranged such that each one filter element is opposite to a switchable image element.

Der Begriff MFK-Anzeigen umfasst hier jedes Matrix-Display mit integrierten nichtlinearen Elementen, d.h. neben der aktiven Matrix auch Anzeigen mit passiven Elementen wie Varistoren oder Dioden (MIM = Metall-Isolator-Metall).The term MFK displays here includes any matrix display with integrated nonlinear elements, ie in addition to the active matrix also displays with passive elements such as varistors or diodes (MIM = metal insulator metal).

Derartige MFK-Anzeigen eignen sich insbesondere für TV-Anwendungen (z.B. Taschenfernseher) oder für hochinformative Displays in Automobil- oder Flugzeugbau. Neben Problemen hinsichtlich der Winkelabhängigkeit des Kontrastes und der Schaltzeiten resultieren bei MFK-Anzeigen Schwierigkeiten bedingt durch einen nicht ausreichend hohen spezifischen Widerstand der Flüssigkristallmischungen [ TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, Sept. 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, p. 141 ff, Par is; STROMER, M., Proc. Eurodisplay 84, Sept. 1984: Design of Thin Film Transistors for Matrix Adressing of Television Liquid Crystal Displays, p. 145 ff, Par is]. Mit abnehmendem Widerstand verschlechtert sich der Kontrast einer MFK-Anzeige. Da der spezifische Widerstand der Flüssigkristallmischung durch Wechselwirkung mit den inneren Oberflächen der Anzeige im allgemeinen über die Lebenszeit einer MFK-Anzeige abnimmt, ist ein hoher (Anfangs)-Widerstand sehr wichtig für Anzeigen die akzeptable Widerstandswerte über eine lange Betriebsdauer aufweisen müssen.Such MFK displays are particularly suitable for TV applications (eg pocket TV) or for high-information displays in automotive or aircraft. In addition to problems with regard to the angle dependence of the contrast and the switching times, difficulties arise in the case of MFK displays due to the insufficiently high specific resistance of the liquid-crystal mixtures [ TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, Sept. 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, p. 141 ff, par is; STROMER, M., Proc. Eurodisplay 84, Sept. 1984: Design of Thin Film Transistors for Matrix Liquid Crystal Displays, p. 145 ff, par is]. As the resistance decreases, the contrast of a MFK display degrades. Since the resistivity of the liquid crystal mixture, through interaction with the internal surfaces of the display, generally decreases over the lifetime of an MFK display, high (initial) resistance is very important for displays that must have acceptable resistance values over a long period of operation.

Es besteht somit immer noch ein großer Bedarf nach MFK-Anzeigen mit sehr hohem spezifischen Widerstand bei gleichzeitig großem Arbeitstemperaturbereich, kurzen Schaltzeiten und niedriger Schwellenspannung, mit deren Hilfe verschiedene Graustufen erzeugt werden können.There is thus still a great need for MFK displays with very high resistivity combined with a large operating temperature range, short switching times and low threshold voltage, with the help of which different gray levels can be generated.

Der Nachteil der häufig verwendeten MFK-TN-Anzeigen beruht in ihrem vergleichsweise niedrigen Kontrast, der relativ hohen Blickwinkelabhängigkeit und der Schwierigkeit in diesen Anzeigen Graustufen zu erzeugen.The drawback of the commonly used MFK TN displays is their relatively low contrast, the relatively high viewing angle dependence, and the difficulty in creating grayscale in these displays.

Wesentlich bessere Blickwinkelabhängigkeiten weisen VA-Displays auf und werden daher hauptsächlich für Fernseher und Monitore verwendet. Hier besteht jedoch weiterhin der Bedarf die Schaltzeiten zu verbessern, insbesondere im Hinblick auf die Verwendung für Fernseher mit "Frame Rates" (Bildwechselfrequenz/Wiederholraten) von mehr als 60 Hz. Dabei dürfen allerdings die Eigenschaften, wie beispielsweise die Tieftemperaturstabilität nicht verschlechtert werden.Significantly better viewing angle dependencies are found on VA displays and are therefore mainly used for TVs and monitors. However, there is still a need to improve the switching times, especially with regard to the use of television sets with "frame rates" (frame rate / repetition rates) of more than 60 Hz. However, the characteristics, such as the low-temperature stability, must not be impaired.

Der Erfindung liegt die Aufgabe zugrunde Flüssigkristallmischungen, wie z.B. bekannt aus DE 10 2012 004871 A1 , WO 2006/002747 A1 , DE 10 2004 012970 A1 , DE10 2011 013007 , EP 2 722 380 A2 und WO 200/017180 A1 , insbesondere für Monitor- und TV-Anwendungen, welche auf dem ECB- oder auf dem IPS- oder FFS-Effekt beruhen, bereitzustellen, die die oben angegebenen Nachteile nicht oder nur in geringerem Maße aufweisen. Insbesondere muss für Monitore und Fernseher gewährleistet sein, dass diese auch bei extrem hohen und extrem niedrigen Temperaturen arbeiten und gleichzeitig sehr niedrige Schaltzeiten aufweisen und gleichzeitig ein verbessertes Reliability-Verhalten, insbesondere kein oder ein deutlich verringertes Image-Sticking nach langen Laufzeiten aufweisen. Bei erhöhten Temperaturen kann beispielsweise eine Zersetzung innerhalb der Flüssigkristall-Mischung eintreten. Unter UV-Belastung wird oftmals eine starke Abnahme des Spannungshaltevermögens (Voltage Holding Ratio (VHR)) beobachtet.The invention is based on the object liquid crystal mixtures, such as known from DE 10 2012 004871 A1 . WO 2006/002747 A1 . DE 10 2004 012970 A1 . DE10 2011 013007 . EP 2 722 380 A2 and WO 200/017180 A1 in particular for monitor and TV applications which are based on the ECB or on the IPS or FFS effect to provide, which have the disadvantages mentioned above, or only to a lesser extent. In particular, it must be ensured for monitors and TVs that they operate at extremely high and extremely low temperatures and at the same time have very low switching times and at the same time have an improved reliability behavior, in particular no or significantly reduced image sticking after long runtimes. For example, at elevated temperatures, decomposition may occur within the liquid crystal mixture. Under UV exposure, a large decrease in Voltage Holding Ratio (VHR) is often observed.

Aufgabe der vorliegenden Erfindung ist es daher Flüssigkristallmischungen bereit zu stellen, die bei erhöhten Temperaturen sowie unter UV-Belastung keine oder keine nennenswerten Probleme bereiten.Object of the present invention is therefore to provide liquid crystal mixtures that cause no or no significant problems at elevated temperatures and under UV exposure.

Überraschenderweise ist es möglich die Reliability und damit die Voltage Holding Ratio nach UV-Belastung (Suntest) zu verbessern ohne den Voltage Holding Ratio Wert vor Belastung zu beeinträchtigen, wenn man Verbindungen der Formel I-1 und/oder I-2 in Flüssigkristallmischungen verwendet, insbesondere in LC-Mischungen mit negativer dielektrischer Anisotropie, vorzugsweise für VA-, IPS- und FFS-Anwendungen, ganz besonders bevorzugt für UB (ultra bright)-FFS-Displays.Surprisingly, it is possible to improve the reliability and thus the voltage holding ratio after UV exposure (Suntest) without adversely affecting the voltage holding ratio value when using compounds of the formula I-1 and / or I-2 in liquid-crystal mixtures. especially in LC blends with negative dielectric anisotropy, preferably for VA, IPS and FFS applications, most preferably for UB (ultra bright )FFS displays.

Gegenstand der Erfindung ist somit ein flüssigkristallines Medium gemäß Anspruch 1, welches die Verbindung der Formel I-1 und/oder die Verbindung der Formel I-2 enthält.The invention thus relates to a liquid-crystalline medium according to claim 1, which contains the compound of formula I-1 and / or the compound of formula I-2.

Die erfindungsgemäßen Mischungen sind sowohl stabil bei erhöhten Temperaturen als auch unter UV-Belastung, zeigen vorzugsweise sehr breite nematische Phasenbereiche mit Klärpunkten ≥ 70 °C, vorzugsweise ≥ 75 °C, insbesondere ≥ 80 °C, sehr günstige Werte für die kapazitive Schwelle, relativ hohe Werte für die Holding Ratio und gleichzeitig sehr gute Tieftemperaturstabilitäten bei -20 °C und -30 °C sowie sehr geringe Rotationsviskositäten und niedrige Schaltzeiten. Die erfindungsgemäßen Mischungen zeichnen sich weiterhin dadurch aus, dass zusätzlich zur Verbesserung der Rotationsviskosität γ1, relativ hohe Werte der elastischen Konstanten K33 zur Verbesserung der Schaltzeiten zu beobachten sind.The mixtures according to the invention are both stable at elevated temperatures and under UV exposure, preferably show very broad nematic phase ranges with clearing points ≥ 70 ° C, preferably ≥ 75 ° C, in particular ≥ 80 ° C, very favorable values for the capacitive threshold, relative high values for the holding ratio and at the same time very good low-temperature stabilities at -20 ° C and -30 ° C as well as very low Rotational viscosities and low switching times. The mixtures according to the invention are further distinguished by the fact that, in addition to the improvement of the rotational viscosity γ 1 , relatively high values of the elastic constants K 33 can be observed to improve the switching times.

Einige bevorzugte Ausführungsformen der erfindungsgemäßen Mischungen werden im Folgenden genannt.Some preferred embodiments of the mixtures according to the invention are mentioned below.

Vorzugsweise wird der flüssigkristallinen Mischung entweder die Verbindung der Formel I-1 oder die Verbindung der Formel I-2 zugesetzt. Die Verbindung I-1 oder I-2 wird in Mengen von 50 - 10000 ppm, insbesondere 100 - 6000 ppm und ganz besonders bevorzugt 300 - 4000 ppm, bezogen auf die flüssigkristalline Mischung eingesetzt. Sofern die Flüssigkristallmischung die Verbindungen I-1 und I-2 enthält, können die beiden Verbindungen in gleichen oder in unterschiedlichen Mengen zugesetzt werden. Die Gesamtkonzentration sollte allerdings 6000 - 10000 ppm bezogen auf die Mischung, nicht übersteigen.Preferably, either the compound of the formula I-1 or the compound of the formula I-2 is added to the liquid-crystalline mixture. The compound I-1 or I-2 is used in amounts of 50-10,000 ppm, in particular 100-6,000 ppm and very particularly preferably 300-4,000 ppm, based on the liquid-crystalline mixture. If the liquid-crystal mixture contains the compounds I-1 and I-2, the two compounds may be added in equal amounts or in different amounts. However, the total concentration should not exceed 6000 - 10000 ppm based on the mixture.

Die Verbindungen der Formeln I-1 und I-2 sind kommerziell erhältlich, z. B. von der Fa. Sigma-Aldrich.The compounds of formulas I-1 and I-2 are commercially available, e.g. B. from the company Sigma-Aldrich.

Im Folgenden werden bevorzugte Ausführungsformen für das erfindungsgemäße flüssigkristalline Medium angeführt:

  1. a) Flüssigkristallines Medium, welches eine oder mehrere Verbindungen ausgewählt aus der Gruppe der Verbindungen der Formeln IIA, IIB und IIC enthält,
    Figure imgb0006
    Figure imgb0007
    Figure imgb0008
    worin
    R2A, R2B und R2C
    jeweils unabhängig voneinander H, einen unsubstituierten, einen einfach durch CN oder CF3 oder mindestens einfach durch Halogen substituierten Alkyl- oder Alkenylrest mit bis zu 15 C-Atomen, wobei in diesen Resten auch eine oder mehrere CH2-Gruppen durch -O-, -S-,
    Figure imgb0009
    -C≡C-, -CF2O-, -OCF2-, -OC-O- oder -O-CO- so ersetzt sein können, dass O-Atome nicht direkt miteinander verknüpft sind, vorzugsweise Alkyl oder Alkenyl mit jeweils 1 bzw. 2-6 C-Atomen,
    L1-4
    jeweils unabhängig voneinander F, Cl, CF3 oder CHF2, vorzugsweise F,
    Z2 und Z2'
    jeweils unabhängig voneinander Einfachbindung, -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -COO-, -OCO-, -C2F4-, -CF=CF-, -CH=CHCH2O-, vorzugsweise eine Einfachbindung, -OCH2- oder -CH2CH2-,
    p
    0, 1 oder 2,
    q
    0 oder 1, und
    v
    1 bis 6
    bedeuten.
Preferred embodiments of the liquid-crystalline medium according to the invention are given below:
  1. a) liquid-crystalline medium which contains one or more compounds selected from the group of the compounds of the formulas IIA, IIB and IIC,
    Figure imgb0006
    Figure imgb0007
    Figure imgb0008
    wherein
    R 2A , R 2B and R 2C
    in each case independently of one another H, an unsubstituted alkyl or alkenyl radical having up to 15 carbon atoms which is monosubstituted by CN or CF 3 or at least monosubstituted by halogen, where one or more CH 2 groups in these radicals are also represented by -O-, -S-,
    Figure imgb0009
    -C≡C, -CF 2 O-, -OCF 2 -, -OC-O- or -O-CO- can be replaced so that O atoms are not directly linked, preferably alkyl or alkenyl, each with 1 or 2-6 C atoms,
    L 1-4
    each independently of one another F, Cl, CF 3 or CHF 2 , preferably F,
    Z 2 and Z 2 '
    each independently represents single bond, -CH 2 CH 2 -, -CH = CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -C 2 F 4 -, -CF = CF-, -CH = CHCH 2 O-, preferably a single bond, -OCH 2 - or -CH 2 CH 2 -,
    p
    0, 1 or 2,
    q
    0 or 1, and
    v
    1 to 6
    mean.

In den Verbindungen der Formeln IIA und IIB können Z2 gleiche oder unterschiedliche Bedeutungen haben. In den Verbindungen der Formel IIB können Z2 und Z2' gleiche oder verschiedene Bedeutungen aufweisen.In the compounds of formulas IIA and IIB, Z 2 may have the same or different meanings. In the compounds of the formula IIB, Z 2 and Z 2 'may have the same or different meanings.

In den Verbindungen der Formeln IIA, IIB und IIC bedeuten R2A, R2B und R2C jeweils vorzugsweise Alkyl oder Alkenyl mit 1 bzw. 2-6 C-Atomen, insbesondere CH3, C2H5, n-C3H7, n-C4H9, n-C5H11., CH2=CH,In the compounds of the formulas IIA, IIB and IIC, R 2A , R 2B and R 2C are each preferably alkyl or alkenyl having 1 or 2 to 6 carbon atoms, in particular CH 3 , C 2 H 5 , nC 3 H 7 , nC 4 H 9 , nC 5 H 11. , CH 2 = CH,

In den Verbindungen der Formeln IIA und IIB bedeuten L1, L2, L3 und L4 vorzugsweise L1 = L2 = F und L3 = L4 = F, ferner L1 = F und L2 = Cl, L1 = Cl und L2 = F, L3 = F und L4 = Cl, L3 = Cl und L4 = F. Z2 und Z2' bedeuten in den Formeln IIA und IIB vorzugsweise jeweils unabhängig voneinander eine Einfachbindung, ferner eine -C2H4- oder eine -CH2O-Brücke.In the compounds of the formulas IIA and IIB, L 1 , L 2 , L 3 and L 4 are preferably L 1 = L 2 = F and L 3 = L 4 = F, furthermore L 1 = F and L 2 = Cl, L 1 = Cl and L 2 = F, L 3 = F and L 4 = Cl, L 3 = Cl and L 4 = F. Z 2 and Z 2 ' in the formulas IIA and IIB preferably each independently a single bond, further a -C 2 H 4 - or a -CH 2 O bridge.

Sofern in der Formel IIB Z2 = -C2H4- oder -CH2O- bedeutet, ist Z2' vorzugsweise eine Einfachbindung bzw. falls Z2' = -C2H4- oder -CH2O- bedeutet, ist Z2 vorzugsweise eine Einfachbindung. In den Verbindungen der Formeln IIA und IIB bedeutet (O)CvH2v+1 vorzugsweise OCvH2v+1, ferner CvH2v+1. In den Verbindungen der Formel IIC bedeutet (O)CvH2v+1 vorzugsweise CvH2v+1. In den Verbindungen der Formel IIC bedeuten L3 und L4 vorzugsweise jeweils F.If in the formula IIB Z 2 = -C 2 H 4 - or -CH 2 O-, Z 2 'is preferably a single bond or if Z 2' = -C 2 H 4 - or -CH 2 O-, Z 2 is preferably a single bond. In the compounds of the formulas IIA and IIB, (O) C v H 2v + 1 preferably denotes OC v H 2v + 1 , furthermore C v H 2v + 1 . In the compounds of the formula IIC, (O) C v H 2v + 1 is preferably C v H 2v + 1 . In the compounds of the formula IIC, L 3 and L 4 are preferably in each case F.

Bevorzugte Verbindungen der Formeln IIA, IIB und IIC werden nachfolgend genannt:

Figure imgb0010
Figure imgb0011
Figure imgb0012
Figure imgb0013
Figure imgb0014
Figure imgb0015
Figure imgb0016
Figure imgb0017
Figure imgb0018
Figure imgb0019
Figure imgb0020
Figure imgb0021
Figure imgb0022
Figure imgb0023
Figure imgb0024
Figure imgb0025
Figure imgb0026
Figure imgb0027
Figure imgb0028
Figure imgb0029
Figure imgb0030
Figure imgb0031
Figure imgb0032
Figure imgb0033
Figure imgb0034
Figure imgb0035
Figure imgb0036
Figure imgb0037
Figure imgb0038
Figure imgb0039
Figure imgb0040
Figure imgb0041
Figure imgb0042
Figure imgb0043
Figure imgb0044
Figure imgb0045
Figure imgb0046
Figure imgb0047
Figure imgb0048
Figure imgb0049
Figure imgb0050
Figure imgb0051
Figure imgb0052
Figure imgb0053
Figure imgb0054
Figure imgb0055
Figure imgb0056
Figure imgb0057
Figure imgb0058
Figure imgb0059
Figure imgb0060
Figure imgb0061
Figure imgb0062
Figure imgb0063
Figure imgb0064
Figure imgb0065
Figure imgb0066
Figure imgb0067
Figure imgb0068
Figure imgb0069
Figure imgb0070
Figure imgb0071
Figure imgb0072
Figure imgb0073
Figure imgb0074
Figure imgb0075
Figure imgb0076
Figure imgb0077
Figure imgb0078
worin Alkyl und Alkyl* jeweils unabhängig voneinander einen geradkettigen Alkylrest mit 1-6 C-Atomen bedeuten.Preferred compounds of the formulas IIA, IIB and IIC are mentioned below:
Figure imgb0010
Figure imgb0011
Figure imgb0012
Figure imgb0013
Figure imgb0014
Figure imgb0015
Figure imgb0016
Figure imgb0017
Figure imgb0018
Figure imgb0019
Figure imgb0020
Figure imgb0021
Figure imgb0022
Figure imgb0023
Figure imgb0024
Figure imgb0025
Figure imgb0026
Figure imgb0027
Figure imgb0028
Figure imgb0029
Figure imgb0030
Figure imgb0031
Figure imgb0032
Figure imgb0033
Figure imgb0034
Figure imgb0035
Figure imgb0036
Figure imgb0037
Figure imgb0038
Figure imgb0039
Figure imgb0040
Figure imgb0041
Figure imgb0042
Figure imgb0043
Figure imgb0044
Figure imgb0045
Figure imgb0046
Figure imgb0047
Figure imgb0048
Figure imgb0049
Figure imgb0050
Figure imgb0051
Figure imgb0052
Figure imgb0053
Figure imgb0054
Figure imgb0055
Figure imgb0056
Figure imgb0057
Figure imgb0058
Figure imgb0059
Figure imgb0060
Figure imgb0061
Figure imgb0062
Figure imgb0063
Figure imgb0064
Figure imgb0065
Figure imgb0066
Figure imgb0067
Figure imgb0068
Figure imgb0069
Figure imgb0070
Figure imgb0071
Figure imgb0072
Figure imgb0073
Figure imgb0074
Figure imgb0075
Figure imgb0076
Figure imgb0077
Figure imgb0078
wherein alkyl and alkyl * each independently represent a straight-chain alkyl radical having 1-6 C atoms.

Besonders bevorzugte erfindungsgemäße Mischungen enthalten eine oder mehrere Verbindungen der Formeln IIA-2, IIA-8, IIA-14, IIA-26, II-28, IIA-33, IIA-39, IIA-45, IIA-46, IIA-47, IIA-50, IIB-2, IIB-11, IIB-16 und IIC-1.Particularly preferred mixtures according to the invention contain one or more compounds of the formulas IIA-2, IIA-8, IIA-14, IIA-26, II-28, IIA-33, IIA-39, IIA-45, IIA-46, IIA-47 , IIA-50, IIB-2, IIB-11, IIB-16 and IIC-1.

Vorzugsweise beträgt der Anteil an Verbindungen der Formeln IIA und/oder IIB im Gesamtgemisch mindestens 20 Gew.%.The proportion of compounds of the formulas IIA and / or IIB in the total mixture is preferably at least 20% by weight.

Besonders bevorzugte erfindungsgemäße Medien enthalten mindestens eine Verbindung der Formel IIC-1,

Figure imgb0079
worin Alkyl und Alkyl*' die oben angegebenen Bedeutungen haben, vorzugsweise in Mengen von > 3 Gew.%, insbesondere > 5 Gew.% und besonders bevorzugt von 5-25 Gew.%.

  • b) Flüssigkristallines Medium, welches zusätzlich eine oder mehrere Verbindungen der Formel III
    Figure imgb0080
    enthält,
    worin
    R31 und R32
    jeweils unabhängig voneinander einen geradkettigen Alkyl-, Alkoxy, Alkenly-, Alkoxyalkyl- oder Alkoxyrest mit bis zu 12 C-Atomen, und
    Figure imgb0081
    Figure imgb0082
    Z3
    Einfachbindung, -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -COO-, -OCO-, -C2F4-, -C4H8-, -CF=CF-
    bedeuten.
    Bevorzugte Verbindungen der Formel III werden nachfolgend genannt,
    Figure imgb0083
    Figure imgb0084
    Figure imgb0085
    Figure imgb0086
    worin
    Alkyl und Alkyl*
    jeweils unabhängig voneinander einen geradkettigen Alkylrest mit 1-6 C-Atomen
    bedeuten.
    Vorzugsweise enthält das erfindungsgemäße Medium mindestens eine Verbindung der Formel IIIa und/oder Formel IIIb.
    Der Anteil an Verbindungen der Formel III im Gesamtgemisch beträgt vorzugsweise mindestens 5 Gew.%.
  • c) Flüssigkristallines Medium enthaltend zusätzlich eine Verbindung der Formel
    Figure imgb0087
    und / oder
    Figure imgb0088
    und / oder
    Figure imgb0089
    vorzugsweise in Gesamtmengen von ≥ 5 Gew.%, insbesondere von ≥ 10 Gew.%.
    Weiterhin bevorzugt sind erfindungsgemäße Mischungen enthaltend die Verbindung der Formel (Acronym: CC-3-V1)
    Figure imgb0090
    vorzugsweise in Mengen von 2-15 %.
    Bevorzugte Mischungen enthalten 5-60 %, vorzugsweise 10-55 %, insbesondere 20-50 Gew.% der Verbindung der Formel (Acronym: CC-3-V)
    Figure imgb0091

    Weiterhin bevorzugt sind Mischungen, die eine Verbindung der Formel (Acronym: CC-3-V)
    Figure imgb0092
    und eine Verbindung der Formel (Acronym: CC-3-V1)
    Figure imgb0093
    enthalten, vorzugsweise in Mengen von 10 - 60 %.
  • d) Flüssigkristallines Medium, welches zusätzlich eine oder mehrere Vierkernverbindungen der Formeln,
    Figure imgb0094
    Figure imgb0095
    Figure imgb0096
    Figure imgb0097
    Figure imgb0098
    Figure imgb0099
    Figure imgb0100
    Figure imgb0101
    Figure imgb0102
    worin
    R7-10
    jeweils unabhängig voneinander eine der in Anspruch 3 für R2A angegebenen Bedeutung haben, und
    w und x
    jeweils unabhängig voneinander 1 bis 6,
    bedeuten,
    enthält.
    Insbesondere bevorzugt sind Mischungen enthaltend mindestens eine Verbindung der Formel V-9.
  • e) Flüssigkristallines Medium, welches zusätzlich eine oder mehrere Verbindungen der Formeln Y-1 bis Y-6,
    Figure imgb0103
    Figure imgb0104
    Figure imgb0105
    Figure imgb0106
    Figure imgb0107
    Figure imgb0108
    enthält,
    worin R14-R19 jeweils unabhängig voneinander einen Alkyl- oder Alkoxyrest mit 1-6 C-Atomen bedeuten; z und m bedeuten jeweils unabhängig voneinander 1-6; x bedeutet 0, 1, 2 oder 3.
    Insbesondere bevorzugt enthält das erfindungsgemäße Medium eine oder mehrere Verbindungen der Formel Y-1 bis Y-6, vorzugsweise in Mengen von ≥ 5 Gew.%.
  • f) Flüssigkristallines Medium enthaltend zusätzlich ein oder mehrere fluorierte Terphenyle der Formeln T-1 bis T-21,
    Figure imgb0109
    Figure imgb0110
    Figure imgb0111
    Figure imgb0112
    Figure imgb0113
    Figure imgb0114
    Figure imgb0115
    Figure imgb0116
    Figure imgb0117
    Figure imgb0118
    Figure imgb0119
    Figure imgb0120
    Figure imgb0121
    Figure imgb0122
    Figure imgb0123
    Figure imgb0124
    Figure imgb0125
    Figure imgb0126
    Figure imgb0127
    Figure imgb0128
    Figure imgb0129
    worin
    R geradkettiger Alkyl- oder Alkoxyrest mit 1-7 C-Atomen bedeutet, und m = 0, 1, 2, 3, 4, 5 oder 6 und n 0, 1, 2, 3 oder 4 bedeuten,
    enthält.
    Vorzugsweise bedeutet R Methyl, Ethyl, Propyl, Butyl, Pentyl, Hexyl Methoxy, Ethoxy, Propoxy, Butoxy, Pentoxy.
    Das erfindungsgemäße Medium enthält ein oder mehrere Terphenyle der Formeln T-1 bis T-21 vorzugsweise in Mengen von 2-30 Gew.%, insbesondere von 5-20 Gew.%.
    Besonders bevorzugt sind Verbindungen der Formeln T-1, T-2, T-4, T-20 und T-21. In diesen Verbindungen bedeutet R vorzugsweise Alkyl, ferner Alkoxy jeweils mit 1-5 C-Atomen. In den Verbindungen der Formel T-20 bedeutet R vorzugsweise Alkyl oder Alkenyl, insbesondere Alkyl. In der Verbindung der Formel T-21 bedeutet R vorzugsweise Alkyl.
    Vorzugsweise werden die Terphenyle in den erfindungsgemäßen Mischungen eingesetzt, wenn der Δn-Wert der Mischung ≥ 0,1 sein soll. Bevorzugte Mischungen enthalten 2-20 Gew.% einer oder mehrerer Terphenyl-Verbindungen ausgewählt aus der Gruppe der Verbindungen T-1 bis T-21.
  • g) Flüssigkristallines Medium enthaltend zusätzlich ein oder mehrere Biphenyle der Formeln B-1 bis B-3,
    Figure imgb0130
    Figure imgb0131
    Figure imgb0132
    worin
    Alkyl und Alkyl*
    jeweils unabhängig voneinander einen geradkettigen Alkylrest mit 1-6 C-Atomen, und
    Alkenyl und Alkenyl*
    jeweils unabhängig voneinander einen geradkettigen Alkenylrest mit 2-6 C-Atomen
    bedeuten.
    Der Anteil der Biphenyle der Formeln B-1 bis B-3 in der Gesamtmischung beträgt vorzugsweise mindestens 3 Gew.%, insbesondere ≥ 5 Gew.%.
    Von den Verbindungen der Formeln B-1 bis B-3 sind die Verbindungen der Formel B-2 insbesondere bevorzugt.
    Besonders bevorzugte Biphenyle sind
    Figure imgb0133
    Figure imgb0134
    Figure imgb0135
    Figure imgb0136
    worin Alkyl* einen Alkylrest mit 1-6 C-Atomen bedeutet. Insbesondere bevorzugt enthält das erfindungsgemäße Medium eine oder mehrere Verbindungen der Formeln B-1a und/oder B-2c.
  • h) Flüssigkristallines Medium enthaltend mindestens eine Verbindung der Formeln Z-1 bis Z-7,
    Figure imgb0137
    Figure imgb0138
    Figure imgb0139
    Figure imgb0140
    Figure imgb0141
    Figure imgb0142
    Figure imgb0143
    Figure imgb0144
    Figure imgb0145
    worin R und Alkyl die oben angegebenen Bedeutungen haben.
  • i) Flüssigkristallines Medium enthaltend mindestens eine Verbindung der Formeln O-1 bis 0-18,
    Figure imgb0146
    Figure imgb0147
    Figure imgb0148
    Figure imgb0149
    Figure imgb0150
    Figure imgb0151
    Figure imgb0152
    Figure imgb0153
    Figure imgb0154
    Figure imgb0155
    Figure imgb0156
    Figure imgb0157
    Figure imgb0158
    Figure imgb0159
    Figure imgb0160
    Figure imgb0161
    Figure imgb0162
    Figure imgb0163
    worin R1 und R2 die für R2A angegebenen Bedeutungen haben. Vorzugsweise bedeuten R1 und R2 jeweils unabhängig voneinander geradkettiges Alkyl oder Alkenyl.
Particularly preferred media according to the invention comprise at least one compound of the formula IIC-1,
Figure imgb0079
wherein alkyl and alkyl * 'have the meanings given above, preferably in amounts of> 3% by weight, in particular> 5% by weight and particularly preferably from 5 to 25% by weight.
  • b) liquid-crystalline medium which additionally contains one or more compounds of the formula III
    Figure imgb0080
    contains
    wherein
    R31 and R32
    each independently of one another a straight-chain alkyl, alkoxy, alkenyl, alkoxyalkyl or alkoxy radical having up to 12 C atoms, and
    Figure imgb0081
    Figure imgb0082
    Z 3
    Single bond, -CH 2 CH 2 -, -CH = CH-, -CF 2 O-, -OCF 2 -, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -C 2 F 4 -, -C 4 H 8 -, -CF = CF-
    mean.
    Preferred compounds of the formula III are mentioned below,
    Figure imgb0083
    Figure imgb0084
    Figure imgb0085
    Figure imgb0086
    wherein
    Alkyl and alkyl *
    each independently a straight-chain alkyl radical having 1-6 C atoms
    mean.
    The medium according to the invention preferably comprises at least one compound of the formula IIIa and / or formula IIIb.
    The proportion of compounds of the formula III in the total mixture is preferably at least 5% by weight.
  • c) Liquid-crystalline medium additionally containing a compound of the formula
    Figure imgb0087
    and or
    Figure imgb0088
    and or
    Figure imgb0089
    preferably in total amounts of ≥ 5% by weight, in particular of ≥ 10% by weight.
    Preference is furthermore given to mixtures according to the invention comprising the compound of the formula (acronym: CC-3-V1)
    Figure imgb0090
    preferably in amounts of 2-15%.
    Preferred mixtures contain 5-60%, preferably 10-55%, in particular 20-50% by weight of the compound of the formula (acronym: CC-3-V)
    Figure imgb0091

    Preference is furthermore given to mixtures which comprise a compound of the formula (acronym: CC-3-V)
    Figure imgb0092
    and a compound of the formula (acronym: CC-3-V1)
    Figure imgb0093
    contained, preferably in amounts of 10 - 60%.
  • d) liquid-crystalline medium which additionally contains one or more four-nucleus compounds of the formulas,
    Figure imgb0094
    Figure imgb0095
    Figure imgb0096
    Figure imgb0097
    Figure imgb0098
    Figure imgb0099
    Figure imgb0100
    Figure imgb0101
    Figure imgb0102
    wherein
    R 7-10
    each independently of one another have one of the meaning given in claim 3 for R 2A , and
    w and x
    each independently from 1 to 6,
    mean,
    contains.
    Particular preference is given to mixtures comprising at least one compound of the formula V-9.
  • e) liquid-crystalline medium which additionally contains one or more compounds of the formulas Y-1 to Y-6,
    Figure imgb0103
    Figure imgb0104
    Figure imgb0105
    Figure imgb0106
    Figure imgb0107
    Figure imgb0108
    contains
    wherein R 14 -R 19 each independently represent an alkyl or alkoxy radical having 1-6 C atoms; z and m are each independently 1-6; x is 0, 1, 2 or 3.
    With particular preference, the medium according to the invention contains one or more compounds of the formula Y-1 to Y-6, preferably in amounts of ≥ 5% by weight.
  • f) liquid-crystalline medium additionally containing one or more fluorinated terphenyls of the formulas T-1 to T-21,
    Figure imgb0109
    Figure imgb0110
    Figure imgb0111
    Figure imgb0112
    Figure imgb0113
    Figure imgb0114
    Figure imgb0115
    Figure imgb0116
    Figure imgb0117
    Figure imgb0118
    Figure imgb0119
    Figure imgb0120
    Figure imgb0121
    Figure imgb0122
    Figure imgb0123
    Figure imgb0124
    Figure imgb0125
    Figure imgb0126
    Figure imgb0127
    Figure imgb0128
    Figure imgb0129
    wherein
    R is straight-chain alkyl or alkoxy radical having 1-7 C atoms, and m is 0, 1, 2, 3, 4, 5 or 6 and n is 0, 1, 2, 3 or 4,
    contains.
    Preferably R is methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy.
    The medium according to the invention contains one or more terphenyls of the formulas T-1 to T-21, preferably in amounts of from 2 to 30% by weight, in particular from 5 to 20% by weight.
    Particular preference is given to compounds of the formulas T-1, T-2, T-4, T-20 and T-21. In these compounds R preferably denotes alkyl, furthermore alkoxy in each case with 1-5 C atoms. In the compounds of the formula T-20, R preferably denotes alkyl or alkenyl, in particular alkyl. In the compound of formula T-21, R is preferably alkyl.
    The terphenyls are preferably used in the mixtures according to the invention if the Δn value of the mixture is to be ≥ 0.1. Preferred mixtures contain 2-20% by weight of one or more terphenyl compounds selected from the group of compounds T-1 to T-21.
  • g) liquid-crystalline medium additionally containing one or more biphenyls of the formulas B-1 to B-3,
    Figure imgb0130
    Figure imgb0131
    Figure imgb0132
    wherein
    Alkyl and alkyl *
    each independently of one another a straight-chain alkyl radical having 1-6 C atoms, and
    Alkenyl and alkenyl *
    each independently a straight-chain alkenyl radical having 2-6 C atoms
    mean.
    The proportion of biphenyls of the formulas B-1 to B-3 in the overall mixture is preferably at least 3% by weight, in particular ≥ 5% by weight.
    Of the compounds of the formulas B-1 to B-3, the compounds of the formula B-2 are particularly preferred.
    Particularly preferred biphenyls are
    Figure imgb0133
    Figure imgb0134
    Figure imgb0135
    Figure imgb0136
    wherein alkyl * is an alkyl radical having 1-6 C atoms. With particular preference, the medium according to the invention contains one or more compounds of the formulas B-1a and / or B-2c.
  • h) liquid-crystalline medium containing at least one compound of the formulas Z-1 to Z-7,
    Figure imgb0137
    Figure imgb0138
    Figure imgb0139
    Figure imgb0140
    Figure imgb0141
    Figure imgb0142
    Figure imgb0143
    Figure imgb0144
    Figure imgb0145
    wherein R and alkyl have the meanings given above.
  • i) liquid-crystalline medium containing at least one compound of the formulas O-1 to 0-18,
    Figure imgb0146
    Figure imgb0147
    Figure imgb0148
    Figure imgb0149
    Figure imgb0150
    Figure imgb0151
    Figure imgb0152
    Figure imgb0153
    Figure imgb0154
    Figure imgb0155
    Figure imgb0156
    Figure imgb0157
    Figure imgb0158
    Figure imgb0159
    Figure imgb0160
    Figure imgb0161
    Figure imgb0162
    Figure imgb0163
    wherein R 1 and R 2 have the meanings given for R 2A . Preferably, R 1 and R 2 are each independently straight-chain alkyl or alkenyl.

Bevorzugte Medien enthalten eine oder mehrere Verbindungen der Formeln O-1, O-3, O-4, 0-6, O-7, 0-10, 0-11, 0-12, 0-14, 0-15, O-16 und/oder 0-17.Preferred media contain one or more compounds of formulas O-1, O-3, O-4, O-6, O-7, O-10, O-11, O-12, O-14, O-15, O -16 and / or 0-17.

Erfindungsgemäße Mischungen enthalten ganz besonders bevorzugt die Verbindungen der Formel O-10, 0-12, 0-16 und/oder O-17, inbesondere in Mengen von 5-30 %.Very particular preference is given to mixtures according to the invention containing the compounds of the formula O-10, O-12, O-16 and / or O-17, in particular in amounts of 5-30%.

Bevorzugte Verbindungen der Formeln O-10 und 0-17 werden nachfolgend genannt:

Figure imgb0164
Figure imgb0165
Figure imgb0166
Figure imgb0167
Figure imgb0168
Figure imgb0169
Preferred compounds of the formulas O-10 and 0-17 are mentioned below:
Figure imgb0164
Figure imgb0165
Figure imgb0166
Figure imgb0167
Figure imgb0168
Figure imgb0169

Besonders bevorzugt enthält das erfindungsgemäße Medium die Dreikern-Verbindungen der Formel O-10a und/oder der Formel O-10b in Kombination mit einer oder mehreren Zweikern-Verbindungen der Formeln O-17a bis O-17d. Vorzugsweise beträgt der Gesamtanteil der Verbindungen der Formel O-10a und/oder O-10b in Kombination mit einer oder mehreren Verbindungen ausgewählt aus den Zweikern-verbindungen der Formeln O-17a bis O-17d 5-40 %, ganz besonders bevorzugt 15-35 %.The medium according to the invention particularly preferably contains the trinuclear compounds of the formula O-10a and / or of the formula O-10b in combination with one or more dinuclear compounds of the formulas O-17a to O-17d. Preferably, the total amount of the compounds of formula O-10a and / or O-10b in combination with one or more compounds selected from the binuclear compounds of the formulas O-17a to O-17d 5-40%, most preferably 15-35%.

Ganz besonders bevorzugte Mischungen enthalten die Verbindungen O-10a und O-17a:

Figure imgb0170
Figure imgb0171
Very particularly preferred mixtures contain the compounds O-10a and O-17a:
Figure imgb0170
Figure imgb0171

Vorzugsweise sind die Verbindungen O-10a und O-17a in der Mischung in einer Konzentration von 15-35 %, besonders bevorzugt von 15-25 % und insbesondere bevorzugt von 18-22 % bezogen auf die Gesamtmischung, enthalten.The compounds O-10a and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and particularly preferably 18-22%, based on the total mixture.

Ganz besonders bevorzugte Mischungen enthalten die Verbindungen O-10b und O-17a:

Figure imgb0172
Figure imgb0173
Very particularly preferred mixtures contain the compounds O-10b and O-17a:
Figure imgb0172
Figure imgb0173

Vorzugsweise sind die Verbindungen O-10b und O-17a in der Mischung in einer Konzentration von 15-35 %, besonders bevorzugt von 15-25 % und insbesondere bevorzugt von 18-22 % bezogen auf die Gesamtmischung, enthalten.The compounds O-10b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and particularly preferably 18-22%, based on the total mixture.

Ganz besonders bevorzugte Mischungen enthalten folgende drei Verbindungen:

Figure imgb0174
Figure imgb0175
Figure imgb0176
Very particularly preferred mixtures contain the following three compounds:
Figure imgb0174
Figure imgb0175
Figure imgb0176

Vorzugsweise sind die Verbindungen O-10a, O-10b und O-17a in der Mischung in einer Konzentration von 15-35 %, besonders bevorzugt von 15-25 % und insbesondere bevorzugt von 18-22 % bezogen auf die Gesamtmischung, enthalten.The compounds O-10a, O-10b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and particularly preferably 18-22%, based on the total mixture.

Bevorzugte Mischungen enthalten mindestens eine Verbindung ausgewählt aus der Gruppe der Verbindungen

Figure imgb0177
Figure imgb0178
Figure imgb0179
worin R1 und R2 die oben angegegebenen Bedeutungen haben. Vorzugsweise bedeutet in den Verbindungen 0-6, 0-7 und O-17 R1 Alkyl oder Alkenyl mit 1-6 bzw. 2-6 C-Atomen und R2 Alkenyl mit 2-6 C-Atomen.Preferred mixtures contain at least one compound selected from the group of compounds
Figure imgb0177
Figure imgb0178
Figure imgb0179
wherein R 1 and R 2 have the meanings given above. In the compounds 0-6, 0-7 and O-17, R 1 preferably denotes alkyl or alkenyl having 1-6 or 2-6 C atoms and R 2 alkenyl having 2-6 C atoms.

Bevorzugte Mischungen enthalten mindestens eine Verbindung ausgewählt aus der Gruppe der Verbindungen der Formeln O-6a, O-6b O-7a, O-7b, O-17e, O-17f, O-17g und O-17h:

Figure imgb0180
Figure imgb0181
Figure imgb0182
Figure imgb0183
Figure imgb0184
Figure imgb0185
Figure imgb0186
Figure imgb0187
worin Alkyl einen Alkylrest mit 1-6 C-Atomen bedeutet. Vorzugsweise sind die Verbindungen der Formel O-6, O-7 und O-17e-h in den erfindungsgemäßen Mischungen mit 1 - 40 Gew.%, vorzugsweise 2 - 35 Gew.% und ganz besonders bevorzugt 2 - 30 Gew.% enthalten.

  • j) Bevorzugte erfindungsgemäße flüssigkristalline Medien enthalten eine oder mehrere Substanzen, die eine Tetrahydronaphthyl- oder Naphthyl-Einheit aufweisen, wie z.B. die Verbindungen der Formeln N-1 bis N-5,
    Figure imgb0188
    Figure imgb0189
    Figure imgb0190
    Figure imgb0191
    Figure imgb0192
    • worin R1N und R2N jeweils unabhängig voneinander die für R2A angegebenen Bedeutungen haben, vorzugsweise geradkettiges Alkyl, geradkettiges Alkoxy oder geradkettiges Alkenyl bedeuten, und
    • Z1 und Z2 jeweils unabhängig voneinander -C2H4-, -CH=CH-, -(CH2)4-, -(CH2)3O-, -O(CH2)3-, -CH=CHCH2CH2-, -CH2CH2CH=CH-, -CH2O-, -OCH2-, -COO-, -OCO-, -C2F4-, -CF=CF-, -CF=CH-, -CH=CF-, -CF2O-, -OCF2-, -CH2- oder eine Einfachbindung
    bedeuten.
  • k) Bevorzugte Mischungen enthalten eine oder mehrere Verbindungen ausgewählt aus der Gruppe der Difluordibenzochroman-Verbindungen der Formel BC, Chromane der Formeln CR, fluorierte Phenanthrene der Formeln PH-1 und PH-2, fluorierte Dibenzofurane der Formeln BF-1 und BF-2,
    Figure imgb0193
    Figure imgb0194
    Figure imgb0195
    Figure imgb0196
    Figure imgb0197
    Figure imgb0198
    worin
    RB1, RB2, RCR1, RCR2, R1, R2 jeweils unabhängig voneinander die Bedeutung von R2A aufweisen. c bedeutet 0, 1 oder 2. d bedeutet 1 oder 2. R1 und R2 bedeuten vorzugsweise unabhängig voneinander Alkyl oder Alkoxy mit 1 bis 6 C-Atomen.
Preferred mixtures contain at least one compound selected from the group of the compounds of the formulas O-6a, O-6b O-7a, O-7b, O-17e, O-17f, O-17g and O-17h:
Figure imgb0180
Figure imgb0181
Figure imgb0182
Figure imgb0183
Figure imgb0184
Figure imgb0185
Figure imgb0186
Figure imgb0187
wherein alkyl is an alkyl radical having 1-6 C atoms. The compounds of the formula O-6, O-7 and O-17e-h are preferably present in the mixtures according to the invention with 1-40% by weight, preferably 2-35% by weight and very particularly preferably 2-30% by weight.
  • j) Preferred liquid-crystalline media according to the invention contain one or more substances which have a tetrahydronaphthyl or naphthyl unit, for example the compounds of the formulas N-1 to N-5,
    Figure imgb0188
    Figure imgb0189
    Figure imgb0190
    Figure imgb0191
    Figure imgb0192
    • wherein R 1N and R 2N each independently of one another have the meanings given for R 2A , preferably straight-chain alkyl, straight-chain alkoxy or straight-chain alkenyl, and
    • Each of Z 1 and Z 2 is independently -C 2 H 4 -, -CH = CH-, - (CH 2 ) 4 -, - (CH 2 ) 3 O-, -O (CH 2 ) 3 -, -CH = CHCH 2 CH 2 -, -CH 2 CH 2 CH = CH-, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -C 2 F 4 -, -CF = CF-, -CF = CH-, -CH = CF-, -CF 2 O-, -OCF 2 -, -CH 2 - or a single bond
    mean.
  • k) Preferred mixtures contain one or more compounds selected from the group of difluorodibenzochroman compounds of the formula BC, chromans of the formulas CR, fluorinated phenanthrenes of the formulas PH-1 and PH-2, fluorinated dibenzofurans of the formulas BF-1 and BF-2,
    Figure imgb0193
    Figure imgb0194
    Figure imgb0195
    Figure imgb0196
    Figure imgb0197
    Figure imgb0198
    wherein
    R B1 , R B2 , CR1 R, R CR2 , R 1 , R 2 each independently have the meaning of R 2A . c is 0, 1 or 2. d is 1 or 2. R 1 and R 2 are preferably independently of one another alkyl or alkoxy having 1 to 6 C atoms.

Die erfindungsgemäßen Mischungen enthalten die Verbindungen der Formeln BC, CR, PH-1, PH-2 und/oder BF vorzugsweise in Mengen von 3 bis 20 Gew.%, insbesondere in Mengen von 3 bis 15 Gew.%.The mixtures according to the invention preferably contain the compounds of the formulas BC, CR, PH-1, PH-2 and / or BF in amounts of from 3 to 20% by weight, in particular in amounts of from 3 to 15% by weight.

Besonders bevorzugte Verbindungen der Formeln BC, CR und BF sind die Verbindungen BC-1 bis BC-7, CR-1 bis CR-5, BF-1a bis BF-1c,

Figure imgb0199
Figure imgb0200
Figure imgb0201
Figure imgb0202
Figure imgb0203
Figure imgb0204
Figure imgb0205
Figure imgb0206
Figure imgb0207
Figure imgb0208
Figure imgb0209
Figure imgb0210
Figure imgb0211
Figure imgb0212
Figure imgb0213
worin

Alkyl und Alkyl*
jeweils unabhängig voneinander einen geradkettigen Alkylrest mit 1-6 C-Atomen, und
Alkenyl und Alkenyl*
jeweils unabhängig voneinander einen geradkettigen Alkenylrest mit 2-6 C-Atomen,
bedeuten.Particularly preferred compounds of the formulas BC, CR and BF are the compounds BC-1 to BC-7, CR-1 to CR-5, BF-1a to BF-1c,
Figure imgb0199
Figure imgb0200
Figure imgb0201
Figure imgb0202
Figure imgb0203
Figure imgb0204
Figure imgb0205
Figure imgb0206
Figure imgb0207
Figure imgb0208
Figure imgb0209
Figure imgb0210
Figure imgb0211
Figure imgb0212
Figure imgb0213
wherein
Alkyl and alkyl *
each independently of one another a straight-chain alkyl radical having 1-6 C atoms, and
Alkenyl and alkenyl *
each independently of one another a straight-chain alkenyl radical having 2-6 C atoms,
mean.

Ganz besonders bevorzugt sind Mischungen enthaltend eine, zwei oder drei Verbindungen der Formel BC-2, BF-1 und/oder BF-2.

  • I) Bevorzugte Mischungen enthalten eine oder mehrere Indan-Verbindungen der Formeln In,
    Figure imgb0214
    worin
    R11, R12, R13
    jeweils unabhängig voneinander einen geradkettigen Alkyl-, Alkoxy-, Alkoxyalkyl- oder Alkenylrest mit 1-6 C-Atomen,
    R12 und R13
    zusätzlich Halogen, vorzugsweise F,
    Figure imgb0215
    i
    0, 1 oder 2
    bedeuten.
    Bevorzugte Verbindungen der Formel In sind die nachfolgend genannten Verbindungen der Formeln In-1 bis In-16,
    Figure imgb0216
    Figure imgb0217
    Figure imgb0218
    Figure imgb0219
    Figure imgb0220
    Figure imgb0221
    Figure imgb0222
    Figure imgb0223
    Figure imgb0224
    Figure imgb0225
    Figure imgb0226
    Figure imgb0227
    Figure imgb0228
    Figure imgb0229
    Figure imgb0230
    Figure imgb0231

    Besonders bevorzugt sind die Verbindungen der Formeln In-1, In-2, In-3 und In-4.
    Die Verbindungen der Formeln In und der Unterformeln In-1 bis In-16 werden vorzugsweise in Konzentrationen ≥ 5 Gew.%, insbesondere 5 - 30 Gew.% und ganz besonders bevorzugt 5 - 25 Gew.% in den erfindungsgemäßen Mischungen eingesetzt.
  • m) Bevorzugte Mischungen enthalten zusätzlich eine oder mehrere Verbindungen der Formeln L-1 bis L-11,
    Figure imgb0232
    Figure imgb0233
    Figure imgb0234
    Figure imgb0235
    Figure imgb0236
    Figure imgb0237
    Figure imgb0238
    Figure imgb0239
    Figure imgb0240
    Figure imgb0241
    Figure imgb0242
    worin
    R, R1 und R2 jeweils unabhängig voneinander die für R2A in Anspruch 5 angegebenen Bedeutungen haben und Alkyl ein Alkylrest mit 1-6 C-Atomen bedeutet. s bedeutet 1 oder 2.
Very particular preference is given to mixtures comprising one, two or three compounds of the formula BC-2, BF-1 and / or BF-2.
  • I) Preferred mixtures contain one or more indane compounds of the formulas In,
    Figure imgb0214
    wherein
    R 11 , R 12 , R 13
    each independently of one another a straight-chain alkyl, alkoxy, alkoxyalkyl or alkenyl radical having 1-6 C atoms,
    R 12 and R 13
    additionally halogen, preferably F,
    Figure imgb0215
    i
    0, 1 or 2
    mean.
    Preferred compounds of the formula In are the following compounds of the formulas In-1 to In-16,
    Figure imgb0216
    Figure imgb0217
    Figure imgb0218
    Figure imgb0219
    Figure imgb0220
    Figure imgb0221
    Figure imgb0222
    Figure imgb0223
    Figure imgb0224
    Figure imgb0225
    Figure imgb0226
    Figure imgb0227
    Figure imgb0228
    Figure imgb0229
    Figure imgb0230
    Figure imgb0231

    Particularly preferred are the compounds of the formulas In-1, In-2, In-3 and In-4.
    The compounds of the formulas In and the sub-formulas In-1 to In-16 are preferably used in concentrations of at least 5% by weight, in particular from 5 to 30% by weight and very particularly preferably from 5 to 25% by weight, in the mixtures according to the invention.
  • m) Preferred mixtures additionally contain one or more compounds of the formulas L-1 to L-11,
    Figure imgb0232
    Figure imgb0233
    Figure imgb0234
    Figure imgb0235
    Figure imgb0236
    Figure imgb0237
    Figure imgb0238
    Figure imgb0239
    Figure imgb0240
    Figure imgb0241
    Figure imgb0242
    wherein
    R, R 1 and R 2 each independently of one another have the meanings given for R 2A in claim 5 and alkyl is an alkyl radical having 1-6 C atoms. s means 1 or 2.

Besonders bevorzugt sind die Verbindungen der Formeln L-1 und L-4, insbesondere L-4.Particular preference is given to the compounds of the formulas L-1 and L-4, in particular L-4.

Die Verbindungen der Formeln L-1 bis L-11 werden vorzugsweise in Konzentrationen von 5 - 50 Gew.%, insbesondere 5 - 40 Gew.% und ganz besonders bevorzugt 10 - 40 Gew.% eingesetzt.The compounds of the formulas L-1 to L-11 are preferably used in concentrations of 5 to 50% by weight, in particular 5 to 40% by weight and very particularly preferably 10 to 40% by weight.

Besonders bevorzugte Mischungskonzepte werden nachfolgend genannt: (Die verwendeten Acronyme sind in Tabelle A erklärt. n und m bedeuten hier jeweils unabhängig voneinander 1-15, vorzugsweise 1-6.)Particularly preferred mixture concepts are mentioned below: (The acronyms used are explained in Table A. n and m here in each case independently of one another denote 1-15, preferably 1-6.)

Die erfindungsgemäßen Mischungen enthalten vorzugsweise

  • CPY-n-Om, insbesondere CPY-2-O2, CPY-3-O2 und/oder CPY-5-02, vorzugsweise in Konzentrationen > 5 %, insbesondere 10-30 %, bezogen auf die Gesamtmischung,
    und/oder
  • CY-n-Om, vorzugsweise CY-3-O2, CY-3-O4, CY-5-O2 und/oder CY-5-04, vorzugsweise in Konzentrationen > 5 %, insbesondere 15-50 %, bezogen auf die Gesamtmischung,
    und/oder
  • CCY-n-Om, vorzugsweise CCY-4-O2, CCY-3-O2, CCY-3-O3, CCY-3-01 und/oder CCY-5-O2, vorzugsweise in Konzentrationen > 5 %, insbesondere 10-30 %, bezogen auf die Gesamtmischung,
    und/oder
  • CLY-n-Om, vorzugsweise CLY-2-O4, CLY-3-O2 und/oder CLY-3-O3, vorzugsweise in Konzentrationen > 5 %, insbesondere 10-30 %, bezogen auf die Gesamtmischung,
    und/oder
  • CK-n-F, vorzugsweise CK-3-F, CK-4-F und/oder CK-5-F, vorzugsweise > 5 %, insbesondere 5-25 %, bezogen auf die Gesamtmischung.
The mixtures according to the invention preferably contain
  • CPY-n-Om, in particular CPY-2-O2, CPY-3-O2 and / or CPY-5-02, preferably in concentrations of> 5%, in particular 10-30%, based on the total mixture,
    and or
  • CY-n-Om, preferably CY-3-O2, CY-3-O4, CY-5-O2 and / or CY-5-04, preferably in concentrations> 5%, in particular 15-50%, based on the total mixture .
    and or
  • CCY-n-Om, preferably CCY-4-O2, CCY-3-O2, CCY-3-O3, CCY-3-01 and / or CCY-5-O2, preferably in concentrations> 5%, in particular 10-30 %, based on the total mixture,
    and or
  • CLY-n-Om, preferably CLY-2-O4, CLY-3-O2 and / or CLY-3-O3, preferably in concentrations> 5%, in particular 10-30%, based on the total mixture,
    and or
  • CK-nF, preferably CK-3-F, CK-4-F and / or CK-5-F, preferably> 5%, in particular 5-25%, based on the total mixture.

Weiterhin bevorzugt sind erfindungsgemäße Mischungen, die folgende Mischungskonzepte enthalten:
(n und m bedeuten jeweils unabhängig voneinander 1-6.)

  • CPY-n-Om und CY-n-Om, vorzugsweise in Konzentrationen von 10-80 % bezogen auf die Gesamtmischung,
    und/oder
  • CPY-n-Om und CK-n-F, vorzugsweise in Konzentrationen von 10-70 % bezogen auf die Gesamtmischung,
    und/oder
  • CPY-n-Om und PY-n-Om, vorzugsweise CPY-2-02 und/oder CPY-3-02 und PY-3-O2, vorzugsweise in Konzentrationen von 10 - 45 % bezogen auf die Gesamtmischung,
    und/oder
  • CPY-n-Om und CLY-n-Om, vorzugsweise in Konzentrationen von 10-80 % bezogen auf die Gesamtmischung.
    und/oder
  • CCVC-n-V, vorzugsweise CCVC-3-V, vorzugsweise in Konzentrationen von 2 - 10 % bezogen auf die Gesamtmischung,
    und/oder
  • CCC-n-V, vorzugsweise CCC-2-V und/oder CCC-3-V, vorzugsweise in Konzentrationen von 2 - 10 % bezogen auf die Gesamtmischung,
    und/oder
  • CC-V-V oder CC-V-V1, vorzugsweise in Konzentrationen von 5 - 50 % bezogen auf die Gesamtmischung.
Preference is furthermore given to mixtures according to the invention which contain the following mixture concepts:
(n and m are each independently 1-6.)
  • CPY-n-Om and CY-n-Om, preferably in concentrations of 10-80% based on the total mixture,
    and or
  • CPY-n-Om and CK-nF, preferably in concentrations of 10-70% based on the total mixture,
    and or
  • CPY-n-Om and PY-n-Om, preferably CPY-2-02 and / or CPY-3-02 and PY-3-O2, preferably in concentrations of 10-45% based on the total mixture,
    and or
  • CPY-n-Om and CLY-n-Om, preferably in concentrations of 10-80% based on the total mixture.
    and or
  • CCVC-nV, preferably CCVC-3-V, preferably in concentrations of 2-10% based on the total mixture,
    and or
  • CCC-nV, preferably CCC-2-V and / or CCC-3-V, preferably in concentrations of 2-10% based on the total mixture,
    and or
  • CC-VV or CC-V-V1, preferably in concentrations of 5 - 50% based on the total mixture.

Ein weiterer Gegenstand der Erfindung ist eine elektrooptische Anzeige mit einer Aktivmatrix-Adressierung basierend auf dem ECB-, VA-, PS-VA-, PA-VA-, IPS-, PS-IPS-, FFS-, UB-FFS- oder PS-FFS-Effekt, dadurch gekennzeichnet, dass sie als Dielektrikum ein flüssigkristallines Medium nach einem oder mehreren der Ansprüche 1 bis 15 enthält.Another object of the invention is an electro-optical display with an active matrix addressing based on the ECB, VA, PS-VA, PA-VA, IPS, PS-IPS, FFS, UB-FFS or PS -FFS effect, characterized in that it contains as a dielectric liquid-crystalline medium according to one or more of claims 1 to 15.

Das erfindungsgemäße flüssigkristalline Medium weist bevorzugt eine nematische Phase von ≤ -20 °C bis ≥ 70 °C, besonders bevorzugt von ≤ -30 °C bis ≥ 80 °C, ganz besonders bevorzugt von ≤ -40 °C bis ≥ 90 °C auf.The liquid-crystalline medium according to the invention preferably has a nematic phase of ≤ -20 ° C to ≥ 70 ° C, more preferably from ≤ -30 ° C to ≥ 80 ° C, most preferably from ≤ -40 ° C to ≥ 90 ° C ,

Hierbei bedeutet der Begriff "eine nematische Phase aufweisen" einerseits, dass bei tiefen Temperaturen bei der entsprechenden Temperatur keine smektische Phase und keine Kristallisation beobachtet wird und andererseits, dass beim Aufheizen aus der nematischen Phase noch keine Klärung auftritt. Die Untersuchung bei tiefen Temperaturen wird in einem Fließviskosimeter bei der entsprechenden Temperatur durchgeführt sowie durch Lagerung in Testzellen einer der elektrooptischen Anwendung entsprechenden Schichtdicke für mindestens 100 Stunden überprüft. Wenn die Lagerstabilität bei einer Temperatur von -20 °C in einer entsprechenden Testzelle 1.000 h oder mehr beträgt, wird das Medium als bei dieser Temperatur stabil bezeichnet. Bei Temperaturen von -30 °C bzw. -40 °C betragen die entsprechenden Zeiten 500 h bzw. 250 h. Bei hohen Temperaturen wird der Klärpunkt nach üblichen Methoden in Kapillaren gemessen.In this case, the term "having a nematic phase" on the one hand means that no smectic phase and no crystallization is observed at low temperatures at the corresponding temperature and, on the other hand, that no clarification occurs during heating from the nematic phase. The investigation at low temperatures is carried out in a flow viscometer at the appropriate temperature and by storage in test cells corresponding to the electro-optical application Layer thickness checked for at least 100 hours. When the storage stability at a temperature of -20 ° C in a corresponding test cell is 1,000 hours or more, the medium is said to be stable at this temperature. At temperatures of -30 ° C or -40 ° C the corresponding times are 500 h or 250 h. At high temperatures, the clearing point is measured in capillaries by conventional methods.

Vorzugsweise weist die Flüssigkristallmischung einen nematischen Phasenbereich von mindestens 60 K und eine Fließviskosität v20 von maximal 30 mm2 · s-1 bei 20 °C auf.The liquid-crystal mixture preferably has a nematic phase range of at least 60 K and a flow viscosity v 20 of at most 30 mm 2 · s -1 at 20 ° C.

Die Werte der Doppelbrechung Δn in der Flüssigkristallmischung liegen in der Regel zwischen 0,07 und 0,16, vorzugsweise zwischen 0,08 und 0,13.The values of the birefringence Δn in the liquid-crystal mixture are generally between 0.07 and 0.16, preferably between 0.08 and 0.13.

Die erfindungsgemäße Flüssigkristallmischung weist ein Δε von -0,5 bis -8,0, insbesondere von -2,5 bis -6,0 auf, wobei Δε die dielektrische Anisotropie bedeutet. Die Rotationsviskosität γ1 bei 20 °C ist vorzugsweise ≤ 150 mPa·s, insbesondere ≤ 120 mPa·s.The liquid-crystal mixture according to the invention has a Δ∈ of -0.5 to -8.0, in particular of -2.5 to -6.0, where Δ∈ denotes the dielectric anisotropy. The rotational viscosity γ 1 at 20 ° C is preferably ≤ 150 mPa · s, especially ≤ 120 mPa · s.

Die erfindungsgemäßen Flüssigkristallmedien weisen relativ kleine Werte für die Schwellenspannung (Vo) auf. Vorzugsweise sind sie im Bereich von 1,7 V bis 3,0 V, besonders bevorzugt ≤ 2,5 V und ganz besonders bevorzugt ≤ 2,3 V.The liquid-crystal media according to the invention have relatively small values for the threshold voltage (Vo). Preferably, they are in the range of 1.7V to 3.0V, more preferably ≤ 2.5V, and most preferably ≤ 2.3V.

Der Begriff "Schwellenspannung" bezieht sich für die vorliegende Erfindung auf die kapazitive Schwelle (V0), auch Freedericksz-Schwelle genannt, sofern nicht explizit anders angegeben.The term "threshold voltage" for the present invention refers to the capacitive threshold (V 0 ), also called Freedericksz threshold, unless explicitly stated otherwise.

Außerdem weisen die erfindungsgemäßen Flüssigkristallmedien hohe Werte für die Voltage Holding Ratio in Flüssigkristallzellen auf.In addition, the liquid-crystal media according to the invention have high values for the voltage holding ratio in liquid-crystal cells.

In der Regel zeigen dabei Flüssigkristallmedien mit einer geringen Ansteuerspannung bzw. Schwellenspannung eine geringere Voltage Holding Ratio als solche mit einer größeren Ansteuerspannung bzw. Schwellenspannung und umgekehrt.As a rule, liquid crystal media with a low drive voltage or threshold voltage show a lower voltage holding ratio than those with a larger drive voltage or threshold voltage and vice versa.

Für die vorliegende Erfindung bedeuten die Begriffe "dielektrisch positive Verbindungen" solche Verbindungen mit einem Δε > 1,5, "dielektrisch neutrale Verbindungen" solche mit -1,5 ≤ Δε ≤ 1,5 und "dielektrisch negative" Verbindungen solche mit Δε < -1,5. Hierbei wird die dielektrische Anisotropie der Verbindungen bestimmt, indem 10 % der Verbindungen in einem flüssigkristallinen Host gelöst werden und von der resultierenden Mischung die Kapazität in mindestens jeweils einer Testzelle mit 20 µm Schichtdicke mit homeotroper und mit homogener Oberflächenorientierung bei 1 kHz bestimmt wird. Die Messspannung beträgt typischerweise 0,5 V bis 1,0 V, sie ist jedoch stets niedriger als die kapazitive Schwelle der jeweiligen untersuchten Flüssigkristallmischung.For the present invention, the terms "dielectrically positive compounds" mean those compounds with a Δε> 1.5, "dielectrically neutral compounds" those with -1.5 ≦ Δε ≦ 1.5 and "dielectrically negative" compounds those with Δε <- 1.5. Here, the dielectric anisotropy of the compounds is determined by 10% of the compounds are dissolved in a liquid crystalline host and the capacity of the resulting mixture in at least one test cell with 20 micron layer thickness is determined with homeotropic and homogeneous surface orientation at 1 kHz. The measurement voltage is typically 0.5 V to 1.0 V, but it is always lower than the capacitive threshold of the liquid crystal mixture under investigation.

Alle angegebenen Werte für Temperaturen für die vorliegende Erfindung sind in °C.All reported temperatures for the present invention are in ° C.

Die erfindungsgemäßen Mischungen sind für alle VA-TFT-Anwendungen geeignet, wie z.B. VAN, MVA, (S)-PVA, ASV, PSA (polymer sustained VA) und PS-VA (polymer stabilized VA). Weiterhin sind sie für IPS (In plane switching) und FFS (Fringe field switching), vorzugsweise UB-FFS, mit negativem Δε geeignet.The mixtures according to the invention are suitable for all VA-TFT applications, such as, for example, VAN, MVA, (S) -PVA, ASV, PSA (polymer-sustained VA) and PS-VA (polymer-stabilized VA). Furthermore, they are for IPS (I n p lane s witching) and FFS (F rings f ield s witching), preferably UB-FFS, with a negative Δε suitable.

Die nematischen Flüssigkristallmischungen in den erfindungsgemäßen Anzeigen enthalten in der Regel zwei Komponenten A und B, die ihrerseits aus einer oder mehreren Einzelverbindungen bestehen.The nematic liquid-crystal mixtures in the displays according to the invention generally contain two components A and B, which in turn consist of one or more individual compounds.

Die Komponente A weist eine deutlich negative dielektrische Anisotropie auf und verleiht der nematischen Phase eine dielektrische Anisotropie von ≤ -0,5. Sie enthält bevorzugt neben eine oder mehrere Verbindungen der Formeln IIA, IIB und/oder IIC, ferner eine oder mehrere Verbindungen der Formel 0-17.The component A has a markedly negative dielectric anisotropy and gives the nematic phase a dielectric anisotropy of ≦ -0.5. It preferably contains, in addition to one or more compounds of the formulas IIA, IIB and / or IIC, furthermore one or more compounds of the formula 0-17.

Der Anteil der Komponente A liegt vorzugsweise zwischen 45 und 100 %, insbesondere zwischen 60 und 100 %.The proportion of component A is preferably between 45 and 100%, in particular between 60 and 100%.

Für Komponente A wird vorzugsweise eine (oder mehrere) Einzelverbindung(en) gewählt, die einen Wert von Δε ≤ -0,8 haben. Dieser Wert muss umso negativer sein, je kleiner der Anteil A an der Gesamtmischung ist.For component A, one (or more) individual compound (s) is preferably selected which have a value of Δε ≦ -0.8. This value must be the more negative the smaller the proportion A of the total mixture is.

Die Komponente B weist eine ausgeprägte Nematogenität und eine Fließviskosität von nicht mehr als 30 mm2·s-1, vorzugsweise nicht mehr als 25 mm2·s-1, bei 20 °C auf.The component B has a pronounced nematogeneity and a flow viscosity of not more than 30 mm 2 .s -1 , preferably not more than 25 mm 2 .s -1 , at 20 ° C.

Dem Fachmann sind aus der Literatur eine Vielzahl geeigneter Materialien bekannt. Besonders bevorzugt sind Verbindungen der Formel 0-17.The skilled worker is known from the literature a variety of suitable materials. Particular preference is given to compounds of the formulas 0-17.

Besonders bevorzugte Einzelverbindungen der Komponente B sind extrem niedrig viskose nematische Flüssigkristalle mit einer Fließviskosität von nicht mehr als 18, vorzugsweise nicht mehr als 12 mm2·s1, bei 20 °C.Particularly preferred individual compounds of component B are extremely low-viscosity nematic liquid crystals having a flow viscosity of not more than 18, preferably not more than 12 mm 2 · s 1 , at 20 ° C.

Komponente B ist monotrop oder enantiotrop nematisch, weist keine smektischen Phasen auf und kann in Flüssigkristallmischungen das Auftreten von smektischen Phasen bis zu sehr tiefen Temperaturen verhindern. Versetzt man beispielsweise eine smektische Flüssigkristallmischung mit jeweils verschiedenen Materialien mit hoher Nematogenität, so kann durch den erzielten Grad der Unterdrückung smektischer Phasen die Nematogenität dieser Materialien verglichen werden.Component B is monotropic or enantiotropic nematic, has no smectic phases and can prevent the occurrence of smectic phases in liquid crystal mixtures up to very low temperatures. If, for example, a smectic liquid-crystal mixture is mixed with in each case different materials with high nematogeneity, the degree of suppression of smectic phases achieved can be used to compare the nematogeneity of these materials.

Optional kann die Mischung auch eine Komponente C enthalten, wobei es sich um Verbindungen mit einer dielektrischen Anisotropie von Δε ≥ 1,5 handelt. Diese sogenannten positiven Verbindungen sind in der Regel in einer Mischung mit negativer dielektrischer Anisotropie in Mengen von ≤ 20 Gew.% bezogen auf die Gesamtmischung enthalten.Optionally, the mixture may also contain a component C, which are compounds having a dielectric anisotropy of Δε ≥ 1.5. These so-called positive compounds are generally contained in a mixture with negative dielectric anisotropy in amounts of ≦ 20% by weight, based on the total mixture.

Sofern die erfindungsgemäße Mischung eine oder mehrere Verbindungen mit einer dielektrischen Anisotropie von Δε ≥ 1,5 enthält, handelt es sich vorzugsweise um eine oder mehrere Verbindungen ausgewählt aus der Gruppe der Verbindungen der Formeln P-1 bis P-4,

Figure imgb0243
Figure imgb0244
Figure imgb0245
Figure imgb0246
worin

R
geradkettiges Alkyl, Alkoxy oder Alkenyl mit jeweils 1 bzw. 2 bis 6 C-Atomen, und
X
F, Cl, CF3, OCF3, OCHFCF3 oder CCF2CHFCF3, vorzugsweise F oder OCF3
bedeuten.If the mixture according to the invention contains one or more compounds having a dielectric anisotropy of Δε ≥ 1.5, it is preferably one or more compounds selected from the group of the compounds of the formulas P-1 to P-4,
Figure imgb0243
Figure imgb0244
Figure imgb0245
Figure imgb0246
wherein
R
straight-chain alkyl, alkoxy or alkenyl having in each case 1 or 2 to 6 C atoms, and
X
F, Cl, CF 3 , OCF 3 , OCHFCF 3 or CCF 2 CHFCF 3 , preferably F or OCF 3
mean.

Vorzugsweise werden die Verbindungen der Formeln P-1 bis P-4 in Konzentrationen von 2 - 15 %, inbesondere 2 - 10 % in den erfindungsgemäßen Mischungen eingesetzt.The compounds of the formulas P-1 to P-4 are preferably used in concentrations of 2 to 15%, in particular 2 to 10%, in the mixtures according to the invention.

Besonders bevorzugt ist die Verbindung der Formel,

Figure imgb0247
, die vorzugsweise in Mengen von 2 - 15 % in den erfindungsgemäßen Mischungen eingesetzt wird.Particularly preferred is the compound of the formula
Figure imgb0247
, which is preferably used in amounts of 2-15% in the mixtures according to the invention.

Daneben können diese Flüssigkristallphasen auch mehr als 18 Komponenten, vorzugsweise 18 bis 25 Komponenten, enthalten.In addition, these liquid crystal phases may also contain more than 18 components, preferably 18 to 25 components.

Vorzugsweise enthalten die Phasen neben der Verbindung der Formel I-1 und/oder I-2, 4 bis 15, insbesondere 5 bis 12, und besonders bevorzugt < 10, Verbindungen der Formeln IIA, IIB und/oder IIC und optional eine oder mehrere Verbindungen der Formel O-17.In addition to the compound of the formula I-1 and / or I-2, the phases preferably contain 4 to 15, in particular 5 to 12, and particularly preferably <10, compounds of the formulas IIA, IIB and / or IIC and optionally one or more compounds the formula O-17.

Neben Verbindungen der Formeln I-1 und/oder I-2 und den Verbindungen der Formeln IIA, IIB und/oder IIC und optional 0-17 können auch noch andere Bestandteile zugegen sein, z. B. in einer Menge von bis zu 45 % der Gesamtmischung, vorzugsweise jedoch bis zu 35 %, insbesondere bis zu 10 %.Besides compounds of the formulas I-1 and / or I-2 and the compounds of the formulas IIA, IIB and / or IIC and optionally 0-17, other constituents may also be present, eg. B. in an amount of up to 45% of the total mixture, but preferably up to 35%, in particular up to 10%.

Die anderen Bestandteile werden vorzugsweise ausgewählt aus den nematischen oder nematogenen Substanzen, insbesondere den bekannten Substanzen, aus den Klassen der Azoxybenzole, Benzylidenaniline, Biphenyle, Terphenyle, Phenyl- oder Cyclohexylbenzoate, Cyclohexan-carbonsäurephenyl- oder -cyclohexylester, Phenylcyclohexane, Cyclohexylbiphenyle, Cyclohexylcyclohexane, Cyclohexylnaphthaline, 1,4-Bis-cyclohexylbiphenyle oder Cylohexylpyrimidine, Phenyl- oder Cyclohexyldioxane, gegebenenfalls halogenierten Stilbenen, Benzylphenylether, Tolane und substituierten Zimtsäureestern.The other constituents are preferably selected from the nematic or nematogenic substances, in particular the known substances, from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, cyclohexane-carboxylic acid phenyl or cyclohexyl esters, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes , 1,4-bis-cyclohexylbiphenyls or cyclohexylpyrimidines, phenyl- or cyclohexyldioxanes, optionally halogenated stilbenes, benzylphenyl ethers, tolans and substituted cinnamic acid esters.

Die wichtigsten als Bestandteile derartiger Flüssigkristallphasen in Frage kommenden Verbindungen lassen sich durch die Formel IV charakterisieren,

        R20-L-G-E-R21     IV

worin L und E je ein carbo- oder heterocyclisches Ringsystem aus der aus 1,4-disubstituierten Benzol- und Cyclohexanringen, 4,4'-disubstituierten Biphenyl-, Phenylcyclohexan- und Cyclohexylcyclohexansystemen, 2,5-disubstituierten Pyrimidin- und 1,3-Dioxanringen, 2,6-disubstituierten Naphthalin, Di- und Tetrahydronaphthalin, Chinazolin und Tetrahydrochinazolin gebildeten Gruppe, G -CH=CH- -N(O)=N- -CH=CQ- -CH=N(O)- -C≡C- -CH2-CH2- -CO-O- -CH2-O- -CO-S- -CH2-S- -CH=N- -COO-Phe-COO- -CF2O- -CF=CF- -OCF2- -OCH2- -(CH2)4- -(CH2)3O- oder eine C-C-Einfachbindung, Q Halogen, vorzugsweise Chlor oder -CN, und R20 und R21 jeweils Alkyl, Alkenyl, Alkoxy, Alkoxyalkyl oder Alkoxycarbonyloxy mit bis zu 18, vorzugsweise bis zu 8 Kohlenstoffatomen, oder einer dieser Reste auch CN, NC, NO2, NCS, CF3, SF5, OCF3, F, Cl oder Br bedeuten.
The most important compounds which can be considered as constituents of such liquid-crystal phases can be characterized by the formula IV

R 20 -LGER 21 IV

wherein L and E are each a carbo- or heterocyclic ring system of the 1,4-disubstituted benzene and cyclohexane rings, 4,4'-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3- Dioxane rings, 2,6-disubstituted naphthalene, di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline, G -CH = CH- -N (O) = N- -CH = CQ -CH = N (O) - -C≡C- CH2-CH2 -CO-O- -CH 2 -O- -CO-S- -CH 2 -S- -CH = N- -COO-Phe-COO- -CF 2 O- CF = CF -OCF 2 - -OCH 2 - - (CH2) 4- - (CH 2 ) 3 O- or a CC single bond, Q is halogen, preferably chlorine or -CN, and R 20 and R 21 are each alkyl, alkenyl, alkoxy, alkoxyalkyl or alkoxycarbonyloxy having up to 18, preferably up to 8 carbon atoms, or one of these radicals also CN, NC , NO 2 , NCS, CF 3 , SF 5 , OCF 3 , F, Cl or Br.

Bei den meisten dieser Verbindungen sind R20 und R21 voneinander verschieden, wobei einer dieser Reste meist eine Alkyl- oder Alkoxygruppe ist. Auch andere Varianten der vorgesehenen Substituenten sind gebräuchlich. Viele solcher Substanzen oder auch Gemische davon sind im Handel erhältlich. Alle diese Substanzen sind nach literaturbekannten Methoden herstellbar.In most of these compounds R 20 and R 21 are different from each other, one of these radicals is usually an alkyl or alkoxy group. Other variants of the proposed substituents are in use. Many such substances or mixtures thereof are commercially available. All these substances can be prepared by literature methods.

Es versteht sich für den Fachmann von selbst, dass die erfindungsgemäße VA-, PALC-, PS-VA, IPS-, PS-IPS, FFS- oder PS-FFS- Mischung auch Verbindungen enthalten kann, worin beispielsweise H, N, O, Cl, F durch die entsprechenden Isotope ersetzt sind.It is self-evident to the person skilled in the art that the VA, PALC, PS-VA, IPS, PS-IPS, FFS or PS-FFS mixture according to the invention can also contain compounds in which, for example, H, N, O, Cl, F are replaced by the corresponding isotopes.

Den erfindungsgemäßen Mischungen können weiterhin polymerisierbare Verbindungen, sogenannte reaktive Mesogene (RMs), beispielsweise wie in U.S. 6,861,107 offenbart, in Konzentrationen von bevorzugt 0,01 - 5 Gew.%, besonders bevorzugt 0,2 - 2 % bezogen auf die Mischung, zugesetzt werden. Optional können diese Mischungen auch einen Initiator enthalten, wie beispielsweise in der U.S 6,781,665 beschrieben. Der Initiator, z.B. Irganox-1076 der Fa. BASF, wird vorzugsweise der Mischung enthaltend polymerisierbare Verbindungen in Mengen von 0-1 % zugesetzt. Derartige Mischungen können für sogenannte Polymer Stabilized VA-Modes (PS-VA) oder PSA (Polymer sustained VA), bei denen eine Polymerisierung der reaktiven Mesogene in der flüssigkristallinen Mischung erfolgen soll, verwendet werden. Voraussetzung hierfür ist, dass die Flüssigkristallmischung selbst keine polymerisierbaren Komponenten enthält, die unter den Bedingungen, wo die RMs polymerisieren, ebenfalls polymerisieren.The mixtures according to the invention may furthermore contain polymerizable compounds, so-called reactive mesogens (RMs), for example in US 6,861,107 disclosed, in concentrations of preferably 0.01 to 5 wt.%, Particularly preferably 0.2 to 2% based on the mixture added. Optionally, these mixtures may also contain an initiator such as described in US 6,781,665. The initiator, for example Irganox-1076 from BASF, is preferably added to the mixture containing polymerizable compounds in amounts of 0-1%. Such mixtures can be used for so-called polymer stabilized VA modes (PS-VA) or PSA (polymer sustained VA), in which a polymerization of the reactive mesogens in the liquid-crystalline mixture is to take place. The prerequisite for this is that the liquid-crystal mixture itself contains no polymerizable components which also polymerize under the conditions where the RMs polymerize.

Die Polymerisation wird vorzugsweise unter folgenden Bedingungen durchgeführt:
Das bzw. die polymerisierbare(n) reaktive(n) Mesogen(e) (RM) wird (werden) in einer Zelle polymerisiert unter Verwendung einer UV-A Lampe definierter Intensität für einen definierten Zeitraum und angelegter Spannung (typischerweise 10 V bis 30 V Wechselspannung, Frequenzen im Bereich von 60 Hz bis 1 kHz). Als UV-A Lichtquelle wird typischerweise eine Halogenmetalldampflampe oder eine Hochdruckquecksilberlampe mit einer Intensität von 50 mW/cm2 eingesetzt.
The polymerization is preferably carried out under the following conditions:
The polymerizable reactive mesogen (s) (RM) is (are) polymerized in a cell using a UV-A lamp of defined intensity for a defined period of time and applied voltage (typically 10V to 30V Alternating voltage, frequencies in the range of 60 Hz to 1 kHz). The UV-A light source used is typically a metal halide lamp or a high-pressure mercury lamp with an intensity of 50 mW / cm 2.

Dies sind Bedingungen, wo beispielsweise flüssigkristalline Verbindungen mit einer Alkenyl- oder Alkenlyoxyseitenkette, wie z. B. die Verbindung der Formel

Figure imgb0248
nicht polymerisieren.These are conditions where, for example, liquid crystalline compounds having an alkenyl or Alkenlyoxyseitenkette, such as. B. the compound of the formula
Figure imgb0248
do not polymerize.

Die erfindungsgemäßen Mischungen können weiterhin übliche Zusätze oder Additive enthalten, wie z.B. Stabilisatoren, Antioxidantien, UV-Absorber, Nanopartikel, Mikropartikel, etc.The mixtures according to the invention may further contain conventional additives or additives, e.g. Stabilizers, antioxidants, UV absorbers, nanoparticles, microparticles, etc.

Der Aufbau der erfindungsgemäßen Flüssigkristallanzeigen entspricht der üblichen Geometrie, wie sie z.B. in EP-OS 0 240 379 , beschrieben wird.The structure of the liquid crystal displays according to the invention corresponds to the usual geometry, as for example in EP-OS 0 240 379 , is described.

Die folgenden Beispiele sollen die Erfindung erläutern, ohne sie zu begrenzen. Vor- und nachstehend bedeuten Prozentangaben Gewichtsprozent; alle Temperaturen sind in Grad Celsius angegeben.The following examples are intended to illustrate the invention without limiting it. Above and below, percentages are by weight; All temperatures are in degrees Celsius.

In der gesamten Patentanmeldung werden 1,4-Cyclohexylenringe und 1,4-Phenylenringe wie folgt dargestellt:

Figure imgb0249
Figure imgb0250
Throughout the patent application, 1,4-cyclohexylene rings and 1,4-phenylene rings are represented as follows:
Figure imgb0249
Figure imgb0250

Bei den Cyclohexylenringen handelt es sich um trans-1,4-Cyclohexylenringe.The cyclohexylene rings are trans-1,4-cyclohexylene rings.

In der gesamten Patentanmeldung sowie in den Ausführungsbeispielen sind die Strukturen der Flüssigkristallverbindungen durch Acronyme angegeben. Sofern nicht anders angegeben, erfolgt die Transformation in chemische Formeln gemäß der Tabellen 1-3. Alle Reste CnH2n+1, CmH2m+1, und Cm'H2m'+1 bzw. CnH2n und CmH2m sind geradkettige Alkylreste bzw. Alkylenreste jeweils mit n, m, m' bzw. z C-Atomen.n, m, m', z bedeuten jeweils unabhängig voneinander 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, vorzugsweise 1, 2, 3, 4, 5 oder 6. In Tabelle 1 sind die Ringelemente der jeweiligen Verbindung codiert, in Tabelle 2 sind die Brückenglieder aufgelistet und in Tabelle 3 sind die Bedeutungen der Symbole für die linken bzw. rechten Seitenketten der Verbindungen angegeben.

Figure imgb0251
Figure imgb0252
Tabelle 2: Brückenglieder E -CH2CH2- V -CH=CH- T -C=C- W -CF2CF2- Z -COO- ZI -OCO- O -CH2O- OI -OCH2- Q -CF2O- QI -OCF2- Tabelle 3: Seitenketten Seitenkette links Seitenkette rechts n- CnH2n+1- -n -CnH2n+1 nO- CnH2n+1-O- -On -O-CnH2n+1 V- CH2=CH- -V -CH=CH2 nV- CnH2n+1-CH=CH- -nV -CnH2n-CH=CH2 Vn- CH2=CH- CnH2n- -Vn -CH=CH-CnH2n+1 nVm- CnH2n+1-CH=CH-CmH2m- -nVm -CnH2n-CH=CH-CmH2m+1 N- N≡C- -N -C≡N F- F- -F -F Cl- Cl- -Cl -Cl M- CFH2- -M -CFH2 D- CF2H- -D -CF2H T- CF3- -T -CF3 MO- CFH2O- -OM -OCFH2 DO- CF2HO- -OD -OCF2H TO- CF3O- -OT -OCF3 T- CF3- -T -CF3 A- H-C≡C- -A -C≡C-H Throughout the patent application as well as in the embodiments, the structures of the liquid crystal compounds are indicated by acronyms. Unless otherwise indicated, the transformation is into chemical formulas according to Tables 1-3. All radicals C n H 2n + 1 , C m H 2m + 1 , and C m ' H 2m' + 1 or C n H 2n and C m H 2m are straight-chain alkyl radicals or alkylene radicals in each case with n, m, m ' or z C atoms.n, m, m ', z are each independently 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, preferably 1, 2, 3, 4, 5 or 6. In Table 1, the ring members of each compound are coded, Table 2 lists the bridge members, and Table 3 shows the meanings of the symbols for the left and right side chains of the compounds, respectively.
Figure imgb0251
Figure imgb0252
<u> Table 2: Jumper links </ u> e -CH 2 CH 2 - V -CH = CH- T -C = C- W -CF 2 CF 2 - Z -COO- ZI -OCO- O -CH 2 O- OI -OCH 2 - Q -CF 2 O- QI -OCF 2 - Side chain on the left Side chain right n- C n H 2n + 1 - -n -C n H 2n + 1 O- C n H 2n + 1 -O- -one -OC n H 2n + 1 V- CH 2 = CH- -V -CH = CH 2 NV C n H 2n + 1 -CH = CH- -nv -C n H 2n -CH = CH 2 Vn CH 2 = CH- C n H 2n - Vn -CH = CH-C n H 2n + 1 NVM C n H2 n + 1 -CH = CH-C m H 2m - -nVm -C n H 2n -CH = CH-C m H 2m + 1 N- N≡C- -N -C≡N F- F- -F -F Cl Cl -Cl -Cl M- CFH 2 - -M -CFH 2 D- CF 2 H -D -CF 2 H T- CF 3 - -T CF3 MO CFH 2 O- -OM -OCFH 2 DO- CF 2 HO- --OD -OCF 2 H TO- CF 3 O- --OT -OCF 3 T- CF 3 - -T -CF 3 A- HC≡C- -A -C≡CH

Vorzugsweise enthalten die erfindungsgemäßen Mischungen neben den Verbindungen der Formel I-1 und/oder I-2 eine oder mehrere Verbindungen der nachfolgend genannten Verbindungen aus der Tabelle A. Tabelle A Folgende Abkürzungen werden verwendet: (n, m, m', z: jeweils unabhängig voneinander 1, 2, 3, 4, 5 oder 6; (O)CmH2m+1 bedeutet OCmH2m+1 oder CmH2m+1)

Figure imgb0253
Figure imgb0254
Figure imgb0255
Figure imgb0256
Figure imgb0257
Figure imgb0258
Figure imgb0259
Figure imgb0260
Figure imgb0261
Figure imgb0262
Figure imgb0263
Figure imgb0264
Figure imgb0265
Figure imgb0266
Figure imgb0267
Figure imgb0268
Figure imgb0269
Figure imgb0270
Figure imgb0271
Figure imgb0272
Figure imgb0273
Figure imgb0274
Figure imgb0275
Figure imgb0276
Figure imgb0277
Figure imgb0278
Figure imgb0279
Figure imgb0280
Figure imgb0281
Figure imgb0282
Figure imgb0283
Figure imgb0284
Figure imgb0285
Figure imgb0286
Figure imgb0287
Figure imgb0288
Figure imgb0289
Figure imgb0290
Figure imgb0291
Figure imgb0292
Figure imgb0293
Figure imgb0294
Figure imgb0295
Figure imgb0296
Figure imgb0297
Figure imgb0298
Figure imgb0299
Figure imgb0300
Figure imgb0301
Figure imgb0302
Figure imgb0303
Figure imgb0304
Figure imgb0305
Figure imgb0306
Figure imgb0307
Figure imgb0308
Figure imgb0309
Figure imgb0310
Figure imgb0311
Figure imgb0312
Figure imgb0313
Figure imgb0314
Figure imgb0315
Figure imgb0316
Figure imgb0317
Figure imgb0318
Figure imgb0319
Figure imgb0320
Figure imgb0321
Figure imgb0322
Figure imgb0323
Figure imgb0324
Figure imgb0325
Figure imgb0326
Figure imgb0327
Figure imgb0328
Figure imgb0329
Figure imgb0330
Figure imgb0331
Figure imgb0332
Figure imgb0333
Figure imgb0334
Figure imgb0335
Figure imgb0336
Figure imgb0337
Figure imgb0338
Figure imgb0339
Figure imgb0340
Figure imgb0341
Figure imgb0342
Figure imgb0343
Figure imgb0344
Figure imgb0345
Figure imgb0346
Figure imgb0347
Figure imgb0348
Figure imgb0349
Figure imgb0350
Figure imgb0351
Figure imgb0352
Figure imgb0353
Figure imgb0354
Figure imgb0355
Figure imgb0356
Figure imgb0357
Figure imgb0358
Figure imgb0359
Figure imgb0360
Figure imgb0361
Figure imgb0362
Figure imgb0363
Figure imgb0364
Figure imgb0365
Figure imgb0366
Figure imgb0367
Figure imgb0368
Figure imgb0369
Figure imgb0370
Figure imgb0371
Figure imgb0372
Figure imgb0373
Figure imgb0374
Figure imgb0375
Figure imgb0376
Figure imgb0377
Figure imgb0378
Figure imgb0379
Figure imgb0380
Figure imgb0381
Figure imgb0382
Figure imgb0383
The mixtures according to the invention preferably contain, in addition to the compounds of the formula I-1 and / or I-2, one or more compounds of the following compounds from Table A. <b><u> Table A </ u></b> The following abbreviations are used: (n, m, m ', z: each independently 1, 2, 3, 4, 5 or 6; (O) C m H 2m + 1 means OC m H 2m + 1 or C m H 2m + 1 )
Figure imgb0253
Figure imgb0254
Figure imgb0255
Figure imgb0256
Figure imgb0257
Figure imgb0258
Figure imgb0259
Figure imgb0260
Figure imgb0261
Figure imgb0262
Figure imgb0263
Figure imgb0264
Figure imgb0265
Figure imgb0266
Figure imgb0267
Figure imgb0268
Figure imgb0269
Figure imgb0270
Figure imgb0271
Figure imgb0272
Figure imgb0273
Figure imgb0274
Figure imgb0275
Figure imgb0276
Figure imgb0277
Figure imgb0278
Figure imgb0279
Figure imgb0280
Figure imgb0281
Figure imgb0282
Figure imgb0283
Figure imgb0284
Figure imgb0285
Figure imgb0286
Figure imgb0287
Figure imgb0288
Figure imgb0289
Figure imgb0290
Figure imgb0291
Figure imgb0292
Figure imgb0293
Figure imgb0294
Figure imgb0295
Figure imgb0296
Figure imgb0297
Figure imgb0298
Figure imgb0299
Figure imgb0300
Figure imgb0301
Figure imgb0302
Figure imgb0303
Figure imgb0304
Figure imgb0305
Figure imgb0306
Figure imgb0307
Figure imgb0308
Figure imgb0309
Figure imgb0310
Figure imgb0311
Figure imgb0312
Figure imgb0313
Figure imgb0314
Figure imgb0315
Figure imgb0316
Figure imgb0317
Figure imgb0318
Figure imgb0319
Figure imgb0320
Figure imgb0321
Figure imgb0322
Figure imgb0323
Figure imgb0324
Figure imgb0325
Figure imgb0326
Figure imgb0327
Figure imgb0328
Figure imgb0329
Figure imgb0330
Figure imgb0331
Figure imgb0332
Figure imgb0333
Figure imgb0334
Figure imgb0335
Figure imgb0336
Figure imgb0337
Figure imgb0338
Figure imgb0339
Figure imgb0340
Figure imgb0341
Figure imgb0342
Figure imgb0343
Figure imgb0344
Figure imgb0345
Figure imgb0346
Figure imgb0347
Figure imgb0348
Figure imgb0349
Figure imgb0350
Figure imgb0351
Figure imgb0352
Figure imgb0353
Figure imgb0354
Figure imgb0355
Figure imgb0356
Figure imgb0357
Figure imgb0358
Figure imgb0359
Figure imgb0360
Figure imgb0361
Figure imgb0362
Figure imgb0363
Figure imgb0364
Figure imgb0365
Figure imgb0366
Figure imgb0367
Figure imgb0368
Figure imgb0369
Figure imgb0370
Figure imgb0371
Figure imgb0372
Figure imgb0373
Figure imgb0374
Figure imgb0375
Figure imgb0376
Figure imgb0377
Figure imgb0378
Figure imgb0379
Figure imgb0380
Figure imgb0381
Figure imgb0382
Figure imgb0383

Die Herstellung der erfindungsgemäß verwendbaren Flüssigkristallmischungen erfolgt in an sich üblicher Weise. In der Regel wird die gewünschte Menge der in geringerer Menge verwendeten Komponenten in der den Hauptbestandteil ausmachenden Komponenten gelöst, zweckmäßig bei erhöhter Temperatur. Es ist auch möglich, Lösungen der Komponenten in einem organischen Lösungsmittel, z.B. in Aceton, Chloroform oder Methanol, zu mischen und das Lösungsmittel nach Durchmischung wieder zu entfernen, beispielsweise durch Destillation.The preparation of the liquid crystal mixtures which can be used according to the invention is carried out in a conventional manner. In general, the desired amount of the components used in lesser amount is dissolved in the constituent of the main component, expediently at elevated temperature. It is also possible to use solutions of the components in an organic solvent, e.g. in acetone, chloroform or methanol, and to remove the solvent again after thorough mixing, for example by distillation.

Mittels geeigneter Zusatzstoffe können die erfindungsgemäßen Flüssigkristallphasen derart modifiziert werden, dass sie in jeder bisher bekannt gewordenen Art von z. B. ECB-, VAN-, IPS-, GH- oder ASM-VA LCD-Anzeige einsetzbar sind.By means of suitable additives, the liquid crystal phases according to the invention can be modified such that they can be used in any type of z. B. ECB, VAN, IPS, GH or ASM-VA LCD display can be used.

Die Dielektrika können auch weitere, dem Fachmann bekannte und in der Literatur beschriebene Additive, wie z. B. UV-Absorber, Antioxidantien, Nanoteilchen, Radikalfänger, enthalten. Beispielsweise können 0-15 % pleochroitische Farbstoffe, Stabilisatoren oder chirale Dotierstoffe zugesetzt werden. Geeignete Stabilisatoren für die erfindungsgemäßen Mischungen sind insbesondere solche die in Tabelle B gelistet sind.The dielectrics may also other, known in the art and described in the literature additives such. As UV absorbers, antioxidants, nanoparticles, radical scavengers included. For example, 0-15% pleochroic dyes, stabilizers or chiral dopants may be added. Suitable stabilizers for the mixtures according to the invention are in particular those listed in Table B.

Beispielsweise können 0-15 % pleochroitische Farbstoffe zugesetzt werden, ferner Leitsalze, vorzugsweise Ethyldimethyldodecylammonium-4-hexoxybenzoat, Tetrabutylammoniumtetraphenylboranat oder Komplexsalze von Kronenethern (vgl. z.B. Haller et al., Mol. Cryst. Liq. Cryst. Band 24, Seiten 249- 258 (1973 )) zur Verbesserung der Leitfähigkeit oder Substanzen zur Veränderung der dielektrischen Anisotropie, der Viskosität und/oder der Orientierung der nematischen Phasen. Derartige Substanzen sind z. B. in den DE-OS 22 09 127 , 22 40 864 , 23 21 632 , 23 38 281 , 24 50 088 , 26 37 430 und 28 53 728 beschrieben.For example, 0-15% pleochroic dyes may be added, further conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf., for example Haller et al., Mol. Cryst. Liq. Cryst. Volume 24, pages 249-258 (1973 )) to improve conductivity or substances for changing the dielectric anisotropy, the viscosity and / or the orientation of the nematic phases. Such substances are z. Tie DE-OS 22 09 127 . 22 40 864 . 23 21 632 . 23 38 281 . 24 50 088 . 26 37 430 and 28 53 728 described.

In der Tabelle B werden mögliche Dotierstoffe angegeben, die den erfindungsgemäßen Mischungen zugesetzt werden können. Sofern die Mischungen einen Dotierstoff enthalten, wird er in Mengen von 0,01-4 Gew.%, vorzugsweise 0,1-1,0 Gew.%, eingesetzt. Tabelle B In der Tabelle B werden mögliche Dotierstoffe angegeben, die in der Regel den erfindungsgemäßen Mischungen zugesetzt werden. Vorzugsweise enthalten die Mischungen 0-10 Gew.%, insbesondere 0,01-5 Gew.% und besonders bevorzugt 0,01-3 Gew.% an Dotierstoffen.

Figure imgb0384
Figure imgb0385
Figure imgb0386
Figure imgb0387
Figure imgb0388
Figure imgb0389
Figure imgb0390
Figure imgb0391
Figure imgb0392
Figure imgb0393
Figure imgb0394
Figure imgb0395
Figure imgb0396
Tabelle C Stabilisatoren, die beispielsweise den erfindungsgemäßen Mischungen in Mengen von 0-10 Gew.% zugesetzt werden können, werden nachfolgend genannt.
Figure imgb0397
Figure imgb0398
Figure imgb0399
Figure imgb0400
n = 1, 2, 3, 4, 5, 6 oder 7
Figure imgb0401
n = 1, 2, 3, 4, 5, 6 oder 7
Figure imgb0402
Figure imgb0403
n = 1, 2, 3, 4, 5, 6 oder 7
Figure imgb0404
Figure imgb0405
Figure imgb0406
Figure imgb0407
Figure imgb0408
Figure imgb0409
Figure imgb0410
Figure imgb0411
Figure imgb0412
Figure imgb0413
Figure imgb0414
Figure imgb0415
Figure imgb0416
Figure imgb0417
Figure imgb0418
Figure imgb0419
Figure imgb0420
Figure imgb0421
Figure imgb0422
Figure imgb0423
Figure imgb0424
Figure imgb0425
Figure imgb0426
Figure imgb0427
Figure imgb0428
Tabelle D In der Tabelle D sind Beispielverbindungen zusammengestellt, die in den FK-Medien gemäß der vorliegenden Erfindung vorzugsweise als reaktive mesogene Verbindungen verwendet werden können. Sofern die erfindungsgemäßen Mischungen ein oder mehrere reaktive Verbindungen enthalten, werden sie vorzugsweise in Mengen von 0,01-5 Gew.% eingesetzt. Gegebenenfalls muss für die Polymerisation noch ein Initiator oder ein Gemisch aus zwei oder mehr Initiatoren zugesetzt werden. Der Initiator oder das Initiatorgemisch wird vorzugsweise in Mengen von 0,001-2 Gew.% bezogen auf die Mischung zugesetzt. Ein geeigneter Initiator ist z. B. Irgacure (Fa. BASF) oder Irganox (Fa. BASF).
Figure imgb0429
RM-1
Figure imgb0430
RM-2
Figure imgb0431
RM-3
Figure imgb0432
RM-4
Figure imgb0433
RM-5
Figure imgb0434
RM-6
Figure imgb0435
RM-7
Figure imgb0436
RM-8
Figure imgb0437
RM-9
Figure imgb0438
RM-10
Figure imgb0439
RM-11
Figure imgb0440
RM-12
Figure imgb0441
RM-13
Figure imgb0442
RM-14
Figure imgb0443
RM-15
Figure imgb0444
RM-16
Figure imgb0445
RM-17
Figure imgb0446
RM-18
Figure imgb0447
RM-19
Figure imgb0448
RM-20
Figure imgb0449
RM-21
Figure imgb0450
RM-22
Figure imgb0451
RM-23
Figure imgb0452
RM-24
Figure imgb0453
RM-25
Figure imgb0454
RM-26
Figure imgb0455
RM-27
Figure imgb0456
RM-28
Figure imgb0457
RM-29
Figure imgb0458
RM-30
Figure imgb0459
RM-31
Figure imgb0460
RM-32
Figure imgb0461
RM-33
Figure imgb0462
RM-34
Figure imgb0463
RM-35
Figure imgb0464
RM-36
Figure imgb0465
RM-37
Figure imgb0466
RM-38
Figure imgb0467
RM-39
Figure imgb0468
RM-40
Figure imgb0469
RM-41
Figure imgb0470
RM-42
Figure imgb0471
RM-43
Figure imgb0472
RM-44
Figure imgb0473
RM-45
Figure imgb0474
RM-46
Figure imgb0475
RM-47
Figure imgb0476
RM-48
Figure imgb0477
RM-49
Figure imgb0478
RM-50
Figure imgb0479
RM-51
Figure imgb0480
RM-52
Figure imgb0481
RM-53
Figure imgb0482
RM-54
Figure imgb0483
RM-55
Figure imgb0484
RM-56
Figure imgb0485
RM-57
Figure imgb0486
RM-58
Figure imgb0487
RM-59
Figure imgb0488
RM-60
Figure imgb0489
RM-61
Figure imgb0490
RM-62
Figure imgb0491
RM-63
Figure imgb0492
RM-64
Figure imgb0493
RM-65
Figure imgb0494
RM-66
Figure imgb0495
RM-67
Figure imgb0496
RM-68
Figure imgb0497
RM-69
Figure imgb0498
RM-70
Figure imgb0499
RM-71
Figure imgb0500
RM-72
Figure imgb0501
RM-73
Figure imgb0502
RM-74
Figure imgb0503
RM-75
Figure imgb0504
RM-76
Figure imgb0505
RM-77
Figure imgb0506
RM-78
Figure imgb0507
RM-79
Figure imgb0508
RM-80
Figure imgb0509
RM-81
Figure imgb0510
RM-82
Figure imgb0511
RM-83
Figure imgb0512
RM-84
Figure imgb0513
RM-85
Figure imgb0514
RM-86
Figure imgb0515
RM-87
Figure imgb0516
RM-88
Figure imgb0517
RM-89
Figure imgb0518
RM-90
Figure imgb0519
RM-91
Figure imgb0520
RM-92
Figure imgb0521
RM-93
Figure imgb0522
RM-94
Figure imgb0523
RM-95
Figure imgb0524
RM-96
Figure imgb0525
RM-97
Figure imgb0526
RM-98
Table B lists possible dopants which can be added to the mixtures according to the invention. If the mixtures contain a dopant, it is used in amounts of 0.01-4% by weight, preferably 0.1-1.0% by weight. <b><u> Table B </ u></b> In Table B possible dopants are given, which are usually added to the mixtures of the invention. Preferably, the mixtures contain 0-10 wt.%, In particular 0.01-5 wt.% And particularly preferably 0.01-3 wt.% Of dopants.
Figure imgb0384
Figure imgb0385
Figure imgb0386
Figure imgb0387
Figure imgb0388
Figure imgb0389
Figure imgb0390
Figure imgb0391
Figure imgb0392
Figure imgb0393
Figure imgb0394
Figure imgb0395
Figure imgb0396
Stabilizers which can be added, for example, to the mixtures according to the invention in amounts of 0-10% by weight are mentioned below.
Figure imgb0397
Figure imgb0398
Figure imgb0399
Figure imgb0400
n = 1, 2, 3, 4, 5, 6 or 7
Figure imgb0401
n = 1, 2, 3, 4, 5, 6 or 7
Figure imgb0402
Figure imgb0403
n = 1, 2, 3, 4, 5, 6 or 7
Figure imgb0404
Figure imgb0405
Figure imgb0406
Figure imgb0407
Figure imgb0408
Figure imgb0409
Figure imgb0410
Figure imgb0411
Figure imgb0412
Figure imgb0413
Figure imgb0414
Figure imgb0415
Figure imgb0416
Figure imgb0417
Figure imgb0418
Figure imgb0419
Figure imgb0420
Figure imgb0421
Figure imgb0422
Figure imgb0423
Figure imgb0424
Figure imgb0425
Figure imgb0426
Figure imgb0427
Figure imgb0428
Table D summarizes example compounds which can be used preferably as reactive mesogenic compounds in the LC media according to the present invention. If the mixtures according to the invention contain one or more reactive compounds, they are preferably used in amounts of 0.01-5% by weight. Optionally, an initiator or a mixture of two or more initiators must be added for the polymerization. The initiator or the initiator mixture is preferably added in amounts of 0.001-2% by weight, based on the mixture. A suitable initiator is z. B. Irgacure (BASF) or Irganox (BASF).
Figure imgb0429
RM-1
Figure imgb0430
RM-2
Figure imgb0431
RM-3
Figure imgb0432
RM-4
Figure imgb0433
RM-5
Figure imgb0434
RM-6
Figure imgb0435
RM-7
Figure imgb0436
RM-8
Figure imgb0437
RM-9
Figure imgb0438
RM-10
Figure imgb0439
RM-11
Figure imgb0440
RM-12
Figure imgb0441
RM-13
Figure imgb0442
RM-14
Figure imgb0443
RM-15
Figure imgb0444
RM-16
Figure imgb0445
RM-17
Figure imgb0446
RM-18
Figure imgb0447
RM-19
Figure imgb0448
RM-20
Figure imgb0449
RM-21
Figure imgb0450
RM-22
Figure imgb0451
RM-23
Figure imgb0452
RM-24
Figure imgb0453
RM-25
Figure imgb0454
RM-26
Figure imgb0455
RM-27
Figure imgb0456
RM-28
Figure imgb0457
RM-29
Figure imgb0458
RM-30
Figure imgb0459
RM-31
Figure imgb0460
RM-32
Figure imgb0461
RM-33
Figure imgb0462
RM-34
Figure imgb0463
RM-35
Figure imgb0464
RM-36
Figure imgb0465
RM-37
Figure imgb0466
RM-38
Figure imgb0467
RM-39
Figure imgb0468
RM-40
Figure imgb0469
RM-41
Figure imgb0470
RM-42
Figure imgb0471
RM-43
Figure imgb0472
RM-44
Figure imgb0473
RM-45
Figure imgb0474
RM-46
Figure imgb0475
RM-47
Figure imgb0476
RM-48
Figure imgb0477
RM-49
Figure imgb0478
RM-50
Figure imgb0479
RM-51
Figure imgb0480
RM-52
Figure imgb0481
RM-53
Figure imgb0482
RM-54
Figure imgb0483
RM-55
Figure imgb0484
RM-56
Figure imgb0485
RM-57
Figure imgb0486
RM-58
Figure imgb0487
RM-59
Figure imgb0488
RM-60
Figure imgb0489
RM-61
Figure imgb0490
RM-62
Figure imgb0491
RM-63
Figure imgb0492
RM-64
Figure imgb0493
RM-65
Figure imgb0494
RM-66
Figure imgb0495
RM-67
Figure imgb0496
RM-68
Figure imgb0497
RM-69
Figure imgb0498
RM-70
Figure imgb0499
RM-71
Figure imgb0500
RM-72
Figure imgb0501
RM-73
Figure imgb0502
RM-74
Figure imgb0503
RM-75
Figure imgb0504
RM-76
Figure imgb0505
RM-77
Figure imgb0506
RM-78
Figure imgb0507
RM-79
Figure imgb0508
RM-80
Figure imgb0509
RM-81
Figure imgb0510
RM-82
Figure imgb0511
RM-83
Figure imgb0512
RM-84
Figure imgb0513
RM-85
Figure imgb0514
RM-86
Figure imgb0515
RM-87
Figure imgb0516
RM-88
Figure imgb0517
RM-89
Figure imgb0518
RM-90
Figure imgb0519
RM-91
Figure imgb0520
RM-92
Figure imgb0521
RM-93
Figure imgb0522
RM-94
Figure imgb0523
RM-95
Figure imgb0524
RM-96
Figure imgb0525
RM-97
Figure imgb0526
RM-98

In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Mischungen eine oder mehrere polymerisierbare Verbindungen, vorzugsweise ausgewählt aus den polymerisierbaren Verbindungen der Formeln RM-1 bis RM-98. Derartige Medien sind insbesondere für PS-FFS- und PS-IPS-Anwendungen geeignet. Von den in der Tabelle D genannten reaktiven Mesogenen sind die Verbindungen RM-1, RM-2, RM-3, RM-4, RM-5, RM-11, RM-17, RM-35, RM-41, RM-44, RM-62 und RM-81 insbesondere bevorzugt.In a preferred embodiment, the mixtures according to the invention comprise one or more polymerizable compounds, preferably selected from the polymerizable compounds of the formulas RM-1 to RM-98. Such media are particularly suitable for PS-FFS and PS-IPS applications. Of the reactive mesogens listed in Table D, the compounds RM-1, RM-2, RM-3, RM-4, RM-5, RM-11, RM-17, RM-35, RM-41, RM- 44, RM-62 and RM-81 are particularly preferred.

Die folgenden Beispiele sollen die Erfindung erläutern, ohne sie zu begrenzen.The following examples are intended to illustrate the invention without limiting it.

Ausführungsbeispieleembodiments

Soweit nicht explizit anders vermerkt, sind in der vorliegenden Anmeldung alle Konzentrationen und %-Werte (mit Ausnahme der Werte für HR, Kontrast und Transmission) in Gewichtsprozent angegeben und beziehen sich auf die jeweilige Gesamtmischung, enthaltend alle festen oder flüssigkristallinen Komponenten, ohne Lösungsmittel.Unless explicitly stated otherwise, in the present application all concentrations and% values (with the exception of the values for HR, contrast and transmission) are given in percent by weight and refer to the respective total mixture containing all solid or liquid-crystalline components, without solvent.

In der vorliegenden Anmeldung sind alle angegebenen Werte für Temperaturen, wie z. B. der Schmelzpunkt T(C,N), der Übergang von der smektischen (S) zur nematischen (N) Phase T(S,N) und der Klärpunkt T(N,I), in Grad Celsius (°C) angegeben. Fp. bedeutet Schmelzpunkt, Kp. = Klärpunkt. Ferner bedeuten K = kristalliner Zustand, N = nematische Phase, S = smektische Phase und I = isotrope Phase. Die Angaben zwischen diesen Symbolen stellen die Übergangstemperaturen dar.In the present application, all values given for temperatures such. For example, the melting point T (C, N), the transition from the smectic (S) to the nematic (N) phase T (S, N) and the clearing point T (N, I), in degrees Celsius (° C). Mp means melting point, bp = clearing point. Furthermore, K = crystalline state, N = nematic phase, S = smectic phase and I = isotropic phase. The information between these symbols represents the transition temperatures.

Als Hostmischung zur Bestimmung der optischen Anisotropie Δn der Verbindungen wird die Verkaufsmischung ZLI-4792 (Fa. Merck KGaA) verwendet. Für die Bestimmung der dielektrischen Anisotropie Δε wird die Verkaufsmischung ZLI-2857 verwendet. Aus der Änderung der Dielektrizitätskonstanten der Hostmischung nach Zugabe der zu untersuchenden Verbindung und Extrapolation auf 100 % der eingesetzten Verbindung werden die physikalischen Daten der zu untersuchenden Verbindung erhalten. Die zu untersuchende Verbindung wird in Abhängigkeit der Löslichkeit in der Regel zu 10 % in der Hostmischung gelöst.As a host mixture for determining the optical anisotropy Δn of the compounds, the sales mixture ZLI-4792 (from Merck KGaA) is used. used. The sales mixture ZLI-2857 is used for the determination of the dielectric anisotropy Δε. From the change in the dielectric constant of the host mixture after addition of the test compound and extrapolation to 100% of the compound used, the physical data of the compound to be tested are obtained. Depending on the solubility, the compound to be tested is usually dissolved at 10% in the host mixture.

Sofern nichts anderes angegeben ist, bedeuten Angaben von Teilen oder Prozent Gewichtsteile bzw. Gewichtsprozent.Unless otherwise indicated, parts are by weight or percentages by weight.

Vor- und nachstehend bedeutenAbove and below mean

ne n e
außerordentlicher Brechungsindex bei 20°C und 589 nm,extraordinary refractive index at 20 ° C and 589 nm,
no n o
ordentlicher Brechungsindex bei 20°C und 589 nm,ordinary refractive index at 20 ° C and 589 nm,
Δn.DELTA.n
optische Anisotropie bei 20°C und 589 nm,optical anisotropy at 20 ° C and 589 nm,
ε ε
dielektrische Suszeptibilität senkrecht zum Direktor bei 20°C und 1 kHz,dielectric susceptibility perpendicular to the director at 20 ° C and 1 kHz,
ε ε
dielektrische Suszeptibilität parallel zum Direktor bei 20°C und 1 kHz,dielectric susceptibility parallel to the director at 20 ° C and 1 kHz,
ΔεΔε
dielektrische Anisotropie bei 20°C und 1 kHz,dielectric anisotropy at 20 ° C and 1 kHz,
Kp., T(N,I)Kp., T (N, I)
Klärpunkt [°C],Clearing point [° C],
γ1 γ 1
Rotationsviskosität gemessen bei 20 °C [mPa·s], bestimmt nach dem Rotationsverfahren in einem magnetischen Feld,Rotational viscosity measured at 20 ° C [mPa · s], determined by the rotation method in a magnetic field,
K1 K 1
elastische Konstante, "Splay"-Deformation bei 20°C, [pN],elastic constant, "splay" deformation at 20 ° C, [pN],
K3 K 3
elastische Konstante, "Bend"-Deformation bei 20°C, [pN],elastic constant, "Bend" deformation at 20 ° C, [pN],
K3 K 3
elastische Konstante, "bend"-Deformation bei 20°C [pN],elastic constant, "bend" deformation at 20 ° C [pN],
LTSLTS
Tieftemperaturstabilität [Low temperature stability (nematische Phase)], bestimmt in Fläschchen mit 1 ml Mischung, Mehrfachbestimmung,Low temperature stability [ L ow t emperature s tability (nematic phase)], determined in vials with 1 ml mixture, multiple determination,
HR20 HR 20
"voltage holding ratio" bei 20°C [%] und"voltage holding ratio" at 20 ° C [%] and
HR100 HR 100
"voltage holding ratio" bei 100°C [%]."voltage holding ratio" at 100 ° C [%].

Alle Konzentrationen in dieser Anmeldung, soweit nicht explizit anders angegeben, beziehen sich auf die entsprechende Mischung oder Mischungskomponente.All concentrations in this application, unless explicitly stated otherwise, refer to the corresponding mixture or mixture component.

Zur Untersuchung der Tieftemperaturstabilität, auch als "LTS" (low temperature stability) bezeichnet, d.h. der Stabilität der FK-Mischung gegen spontane Auskristallisation einzelner Komponenten bei tiefen Temperaturen, werden Fläschchen mit 1 ml FK/RM-Mischung bei Temperaturren zwischen 0 °C und -30 °C eingelagert und es wird regelmäßig überprüft, ob die Mischungen auskristallisiert waren.To study low temperature stability, also referred to as "LTS" (low temperature stability), i. the stability of the LC mixture against spontaneous crystallization of individual components at low temperatures, vials are stored with 1 ml FK / RM mixture at Temperaturren between 0 ° C and -30 ° C and it is checked regularly whether the mixtures were crystallized.

Der VHR-Wert wird wie folgt gemessen: Zur FK-Host-Mischung werden ggf. die Verbindung der Formel I-1 und/oder I-2 und die dadurch entstandene Mischung in TN-VHR-Testzellen gefüllt (90° gerieben, Orientierungsschicht TN-Polyimid (z.B. SE 2414 Nissan Chemicals, oder AL-16301, JSR, Schichtdicke d ≈ 6 µm). Der HR-Wert wird entweder bei Raumtemperatur (RT) oder nach 5 min bei 100 °C vor und nach 0,5 h oder 2 h UV-Belastung (suntest) bei 1 V, 60 Hz, 64 µs pulse bestimmt (Messgerät: Autronic-Melchers VHRM-105).The VHR value is measured as follows: The FK-host mixture is optionally filled with the compound of the formula I-1 and / or I-2 and the resulting mixture in TN-VHR test cells (90 ° rubbed, orientation layer TN Polyimide (eg SE 2414 Nissan Chemicals, or AL-16301, JSR, layer thickness d ≈ 6 μm) The HR value is measured either at room temperature (RT) or after 5 min at 100 ° C before and after 0.5 h or 2 h UV exposure (suntest) at 1 V, 60 Hz, 64 μs pulse determined (measuring device: Autronic-Melcher's VHRM-105).

Die sogenannte "HTP" ("helical twisting power") bezeichnet das helikale Verdrillungsvermögen einer optisch aktiven bzw. chiralen Substanz in einerm FK-Medium (in µm). Falls nicht anders angegeben, wird die HTP in der kommerziell erhältlichen nematischen FK-Hostmischung MLC-6260 (Merck KGaA) bei einer Temperatur von 20 °C gemessen.The so-called "helical twisting power" (HTP) refers to the helical twisting power of an optically active or chiral substance in a FK medium (in μm). Unless otherwise stated, HTP is measured in the commercially available nematic FK host mixture MLC-6260 (Merck KGaA) at a temperature of 20 ° C.

Alle physikalischen Eigenschaften werden und wurden nach " Merck Liquid Crystals, Physical Properties of Liquid Crystals", Status November 1997, Merck KGaA , Deutschland bestimmt und gelten für eine Temperatur von 20°C, sofern nicht explizit anders angegeben.All physical properties are and have been " Merck Liquid Crystals, Physical Properties of Liquid Crystals ", status November 1997, Merck KGaA , Germany and are valid for a temperature of 20 ° C, unless explicitly stated otherwise.

MischungsbeispieleExamples mix Beispiel M1 (= Vergleichsbeispiel M1) Example M1 (= Comparative Example M1)

CY-3-O2CY-3-O2 12,00 %12.00% Klärpunkt [°C]:Clearing point [° C]: 86,586.5 CY-3-O4CY-3-O4 2,00 %2.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,1092.1092 CY-5-O2CY-5-O2 12,00 %12.00% Δε [1 kHz, 20 °C]:Δε [1 kHz, 20 ° C]: -4,2-4.2 CCY-3-O1CCY-3-O1 6,00 %6.00% ε [1 kHz, 20 °C]:ε [1 kHz, 20 ° C]: 3,73.7 CCY-3-O2CCY-3-O2 8,00 %8.00% K3 [pN, 20 °C]:K 3 [pN, 20 ° C]: 16,616.6 CCY-4-O2CCY-4-O2 8,00 %8.00% K3/K1 [20 °C]:K 3 / K 1 [20 ° C]: 1,141.14 CPY-2-O2CPY-2-O2 9,00 %9.00% γ1 [mPa·s, 20 °C]:γ 1 [mPa.s, 20 ° C]: 155155 CPY-3-O2CPY-3-O2 9,00 %9.00% LTS Bulk (-30 °C):LTS bulk (-30 ° C): > 1000 h> 1000 h PYP-2-3PYP 2-3 5,00 %5.00% CC-3-V1CC-3-V1 5,00 %5.00% CC-3-VCC-3-V 19,00 %19.00% BCH-32BCH-32 5,00 %5.00%

Zu der Mischung gemäß Beispiel 1 wird die Verbindung I-1To the mixture according to Example 1, the compound I-1

Figure imgb0527
in unterschiedlichen Konzentrationen zugesetzt und die VHR bei den genannten Konditionen bestimmt. VHR M1 M1 + I-1 100 ppm M1 + I-1 300 ppm M1 + I-1 600 ppm VHR (60 Hz, initial, RT): 99,7 % 99,6 % 99,6 % 99,6 % VHR (60 Hz; 0,5 h Suntest, RT): 99,1 % 98,8 % 99,3 % 99,4 % VHR (10 Hz, initial, RT): 99,1 % 98,9 % 99,0 % 99,1 % VHR (10 Hz; 0,5 h Suntest, RT): 95,7 % 94,6 % 97,0 % 97,6 %
Figure imgb0527
added in different concentrations and the VHR determined under the conditions mentioned. VHR M1 M1 + I-1 100 ppm M1 + I-1 300 ppm M1 + I-1 600 ppm VHR (60 Hz, initial, RT): 99.7% 99.6% 99.6% 99.6% VHR (60 Hz, 0.5 h Suntest, RT): 99.1% 98.8% 99.3% 99.4% VHR (10 Hz, initial, RT): 99.1% 98.9% 99.0% 99.1% VHR (10 Hz, 0.5 h Suntest, RT): 95.7% 94.6% 97.0% 97.6%

Beispiel M2 (= Vergleichsbeispiel M2) Example M2 (= Comparative Example M2)

CY-3-O2CY-3-O2 12,00 %12.00% Klärpunkt [°C]:Clearing point [° C]: 86,586.5 CY-3-O4CY-3-O4 2,00 %2.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,1092.1092 CY-5-O2CY-5-O2 12,00 %12.00% Δε [1 kHz, 20 °C]:Δε [1 kHz, 20 ° C]: -4,2-4.2 CCY-3-O1CCY-3-O1 6,00 %6.00% ε [1 kHz, 20 °C]:ε [1 kHz, 20 ° C]: 3,73.7 CCY-3-O2CCY-3-O2 8,00 %8.00% K3 [pN, 20 °C]:K 3 [pN, 20 ° C]: 16,616.6 CCY-4-O2CCY-4-O2 8,00 %8.00% K3/K1 [20 °C]:K 3 / K 1 [20 ° C]: 1,141.14 CPY-2-O2CPY-2-O2 9,00 %9.00% γ1 [mPa·s, 20 °C]:γ 1 [mPa.s, 20 ° C]: 155155 CPY-3-O2CPY-3-O2 9,00 %9.00% LTS Bulk (-30 °C):LTS bulk (-30 ° C): > 1000 h> 1000 h PYP-2-3PYP 2-3 5,00 %5.00% CC-3-V1CC-3-V1 5,00 %5.00% CC-3-VCC-3-V 19,00 %19.00% BCH-32BCH-32 5,00 %5.00%

Zu der Mischung gemäß Beispiel 2 wird die Verbindung I-2To the mixture according to Example 2, the compound I-2

Figure imgb0528
in unterschiedlichen Konzentrationen zugesetzt und die VHR bei den genannten Konditionen bestimmt. VHR M2 M2 + I-2 300 ppm M2 + I-2 600 ppm M2 + I-2 1000 ppm VHR (60 Hz, initial, RT): 99,6 % 99,6 % 99,6 % 99,6 % VHR (60 Hz; 0,5 h Suntest, RT): 97,9 % 98,8 % 98,9 % 99,0 % VHR 10 Hz, initial, RT): 98,8 % 99,0 % 98,9 % 99,0 % VHR (10 Hz; 0,5 h Suntest, RT): 89,0 % 93,9 % 94,3 % 95,1 % VHR M2 M2 + I-2 2000 ppm M2 + I-2 4000 ppm VHR (60 Hz, initial, RT): 99,6 % 99,6 % 99,6 % VHR (60 Hz; 0,5 h Suntest, RT): 97,9 % 99,0 % 99,0 % VHR 10 Hz, initial, RT): 98,8 % 98,9 % 98,9 % VHR (10 Hz; 0,5 h Suntest, RT): 89,0 % 95,2 % 94,9 %
Figure imgb0528
added in different concentrations and the VHR determined under the conditions mentioned. VHR M2 M2 + I-2 300 ppm M2 + I-2 600 ppm M2 + I-2 1000 ppm VHR (60 Hz, initial, RT): 99.6% 99.6% 99.6% 99.6% VHR (60 Hz, 0.5 h Suntest, RT): 97.9% 98.8% 98.9% 99.0% VHR 10 Hz, initial, RT): 98.8% 99.0% 98.9% 99.0% VHR (10 Hz, 0.5 h Suntest, RT): 89.0% 93.9% 94.3% 95.1% VHR M2 M2 + I-2 2000 ppm M2 + I-2 4000 ppm VHR (60 Hz, initial, RT): 99.6% 99.6% 99.6% VHR (60 Hz, 0.5 h Suntest, RT): 97.9% 99.0% 99.0% VHR 10 Hz, initial, RT): 98.8% 98.9% 98.9% VHR (10 Hz, 0.5 h Suntest, RT): 89.0% 95.2% 94.9%

Analoge Ergebnisse für die Voltage Holding Ratio werden mit den Mischungen gemäß der Beispiele M3 bis M10 erzielt.Analogous results for the voltage holding ratio are achieved with the mixtures according to examples M3 to M10.

Beispiel M3 (= Vergleichsbeispiel M3) Example M3 (= Comparative Example M3) Die nachfolgende LC-MischungThe following LC mixture

CY-3-O2 22,00 % Klärpunkt [°C]: 79,5 CY-5-O2 2,00 % Δn [589 nm, 20 °C]: 0,0942 CCOY-3-O2 8,00 % Δε [1kHz,20 °C]: -3,0 CPY-2-O2 7,00 % ε [1kHz,20 °C]: 3,4 CPY-3-O2 10,00 % K3 [pN, 20 °C]: 15,5 CCH-34 6,00 % K3/K1 [20 °C]: 1,08 CCH-23 22,00 % γ1 [mPa·s, 20 °C]: 112 CCP-3-3 7,50 % V0 [20 °C,V]: 2,41 CCP-3-1 7,00 % VHR (initial): 98,6 % BCH-32 6,00 % VHR (15 minUVA): 94,5 % PCH-301 2,50 % VHR (2 minUVA+ 2h suntest): 91,6% wird mit 600 ppm der Verbindung der Formel I-1 stabilisiert. CY-3-O2 22.00% Clearing point [° C]: 79.5 CY-5-O2 2.00% Δn [589 nm, 20 ° C]: 0.0942 CCOY-3-O2 8.00% Δε [1kHz, 20 ° C]: -3.0 CPY-2-O2 7.00% ε [1kHz, 20 ° C]: 3.4 CPY-3-O2 10.00% K 3 [pN, 20 ° C]: 15.5 CCH-34 6.00% K 3 / K 1 [20 ° C]: 1.08 CCH-23 22.00% γ 1 [mPa.s, 20 ° C]: 112 CCP 3-3 7.50% V 0 [20 ° C, V]: 2.41 CCP 3-1 7.00% VHR (initial): 98.6% BCH-32 6.00% VHR (15 minUVA): 94.5% PCH-301 2.50% VHR (2 minUVA + 2h suntest): 91.6% is stabilized with 600 ppm of the compound of formula I-1.

Beispiel M4 (= Vergleichsbeispiel M4) Example M4 (= Comparative Example M4) Die nachfolgende LC-MischungThe following LC mixture

CY-3-O2 12,00 % Klärpunkt [°C]: 79,5 COY-3-O2 12,00 % Δn [589 nm, 20 °C]: 0,0955 CCY-3-O2 4,00 % Δε [1 kHz, 20 °C]: -3,0 CPY-2-O2 9,00 % ε [1 kHz, 20 °C]: 3,4 CPY-3-O2 10,00 % K3 [pN, 20 °C]: 15,3 CCH-34 6,00 % K3/K1 [20 °C]: 1,03 CCH-23 22,00 % γ1 [mPa·s, 20 °C]: 108 CCP-3-3 8,00 % V0 [20 °C, V]: 2,39 CCP-3-1 8,00 % VHR (initial): 98,4 % BCH-32 6,00 % VHR (15 min UVA): 93,5% PCH-301 3,00 % VHR (2 minUVA+ 2h suntest): 89,0% wird mit 1000 ppm der Verbindung der Formel I-2 stabilisiert. CY-3-O2 12.00% Clearing point [° C]: 79.5 COY 3-O2 12.00% Δn [589 nm, 20 ° C]: 0.0955 CCY-3-O2 4.00% Δε [1 kHz, 20 ° C]: -3.0 CPY-2-O2 9.00% ε [1 kHz, 20 ° C]: 3.4 CPY-3-O2 10.00% K 3 [pN, 20 ° C]: 15.3 CCH-34 6.00% K 3 / K 1 [20 ° C]: 1.03 CCH-23 22.00% γ 1 [mPa.s, 20 ° C]: 108 CCP 3-3 8.00% V 0 [20 ° C, V]: 2.39 CCP 3-1 8.00% VHR (initial): 98.4% BCH-32 6.00% VHR (15 min UVA): 93.5% PCH-301 3.00% VHR (2 minUVA + 2h suntest): 89.0% is stabilized with 1000 ppm of the compound of formula I-2.

Beispiel M5 (= Vergleichsbeispiel M5) Example M5 (= comparative example M5) Die nachfolgende LC-MischungThe following LC mixture

COY-3-O2 21,00 % Klärpunkt [°C]: 79,5 CCY-3-O2 3,00 % Δn [589 nm, 20 °C]: 0,0959 CPY-2-O2 10,00 % Δε [1kHz,20 °C]: -3,0 CPY-3-O2 10,00 % ε [1kHz,20 °C]: 3,5 CCH-34 6,00 % K3 [pN, 20 °C]: 14,9 CCH-23 22,00 % K3/K1 [20 °C]: 1,03 CCP-3-3 8,00 % γ1 [mPa·s, 20 °C]: 108 CCP-3-1 8,00 % VHR (initial): 98,4 % BCH-32 6,00 % VHR (15 min UVA): 91,0 % PCH-301 6,00 % VHR (2 minUVA+ 2h suntest): 86,4% wird mit 400 ppm der Verbindung der Formel I-1 stabilisiert. COY 3-O2 21.00% Clearing point [° C]: 79.5 CCY-3-O2 3.00% Δn [589 nm, 20 ° C]: .0959 CPY-2-O2 10.00% Δε [1kHz, 20 ° C]: -3.0 CPY-3-O2 10.00% ε [1kHz, 20 ° C]: 3.5 CCH-34 6.00% K 3 [pN, 20 ° C]: 14.9 CCH-23 22.00% K 3 / K 1 [20 ° C]: 1.03 CCP 3-3 8.00% γ 1 [mPa.s, 20 ° C]: 108 CCP 3-1 8.00% VHR (initial): 98.4% BCH-32 6.00% VHR (15 min UVA): 91.0% PCH-301 6.00% VHR (2 minUVA + 2h suntest): 86.4% is stabilized with 400 ppm of the compound of formula I-1.

Beispiel M6 (= Vergleichsbeispiel M6) Example M6 (= comparative example M6) Die nachfolgende LC-MischungThe following LC mixture

COY-3-O2 16,00 % Klärpunkt [°C]: 81,0 CCY-3-O2 9,00 % Δn [589 nm, 20 °C]: 0,0931 CPY-2-O2 5,00 % Δε [1 kHz,20 °C]: -2,9 CPY-3-O2 10,00 % K1[pN, 20 °C]: 15,0 CCH-34 7,00 % K3[pN, 20 °C]: 15,6 CCH-23 21,00 % γ1 [mPa·s, 20 °C]: 108 CCP-3-3 6,00 % V0 [20 °C,V]: 2,42 CCP-3-1 10,00 % BCH-32 6,00 % Y-4O-O4 7,00 % CBC-33 3,00 % wird mit 2000 ppm der Verbindung der Formel I-2 stabilisiert. COY 3-O2 16.00% Clearing point [° C]: 81.0 CCY-3-O2 9.00% Δn [589 nm, 20 ° C]: 0.0931 CPY-2-O2 5.00% Δε [1 kHz, 20 ° C]: -2.9 CPY-3-O2 10.00% K 1 [pN, 20 ° C]: 15.0 CCH-34 7.00% K 3 [pN, 20 ° C]: 15.6 CCH-23 21.00% γ 1 [mPa.s, 20 ° C]: 108 CCP 3-3 6.00% V 0 [20 ° C, V]: 2.42 CCP 3-1 10.00% BCH-32 6.00% Y-4O-O4 7.00% CBC 33 3.00% is stabilized with 2000 ppm of the compound of formula I-2.

Beispiel M7 (= Vergleichsbeispiel M7) Example M7 (= Comparative Example M7) Die nachfolgende LC-MischungThe following LC mixture

COY-3-O2 15,00 % Klärpunkt [°C]: 74,5 CCOY-3-O2 5,00 % Δn [589 nm, 20 °C]: 0,1069 CCY-3-O2 6,00 % Δε [1 kHz, 20 °C]: -3,0 CPY-2-O2 8,00 % K1[pN, 20 °C]: 14,0 CPY-3-O2 10,00 % K3[pN, 20 °C]: 14,7 CCH-23 24,00 % γ1 [mPa·s, 20 °C]: 104 CCH-34 5,00 % V0 [20 °C, V]: 2,34 PYP-2-3 10,00 % PYP-2-4 5,00 % CC-3-V1 10,00 % PCH-301 2,00 % wird mit 2000 ppm der Verbindung der Formel I-2 stabilisiert. COY 3-O2 15.00% Clearing point [° C]: 74.5 CCOY-3-O2 5.00% Δn [589 nm, 20 ° C]: .1069 CCY-3-O2 6.00% Δε [1 kHz, 20 ° C]: -3.0 CPY-2-O2 8.00% K 1 [pN, 20 ° C]: 14.0 CPY-3-O2 10.00% K 3 [pN, 20 ° C]: 14.7 CCH-23 24.00% γ 1 [mPa.s, 20 ° C]: 104 CCH-34 5.00% V 0 [20 ° C, V]: 2.34 PYP 2-3 10.00% PYP 2-4 5.00% CC-3-V1 10.00% PCH-301 2.00% is stabilized with 2000 ppm of the compound of formula I-2.

Beispiel M8 (= Vergleichsbeispiel M8) Example M8 (= comparative example M8) Die nachfolgende LC-MischungThe following LC mixture

CC-3-V 32,00 % Klärpunkt [°C]: 75 PP-1-3 2,30 % Δn [589 nm, 20 °C]: 0,1021 CC-3-V1 6,70 % Δε [1 kHz, 20 °C]: -3,7 PY-3-O2 8,10 % K1[pN, 20 °C]: 12,9 PY-V2-O2 7,35 % K3[pN, 20 °C]: 15,5 CEY-3-O2 2,75 % γ1 [mPa·s, 20 °C]: 96 CCP-V-1 4,60 % V0 [20 °C, V]: 2,15 CCY-V-O1 5,60 % CCY-V-O2 9,40 % CPY-V-O2 4,80 % CAIY-3-O2 6,85 % CCY-V-O4 7,60 % CPY-V-O4 1,95 % wird mit 2000 ppm der Verbindung der Formel I-2 stabilisiert. CC-3-V 32.00% Clearing point [° C]: 75 PP-1-3 2.30% Δn [589 nm, 20 ° C]: .1021 CC-3-V1 6,70% Δε [1 kHz, 20 ° C]: -3.7 PY-3-O2 8.10% K 1 [pN, 20 ° C]: 12.9 PY-V2-O2 7.35% K 3 [pN, 20 ° C]: 15.5 CEY-3-O2 2.75% γ 1 [mPa.s, 20 ° C]: 96 CCP-V-1 4,60% V 0 [20 ° C, V]: 2.15 CCY-V O1 5.60% CCY-V O2 9.40% CPY-V O2 4.80% CAIY-3-O2 6.85% CCY-V O4 7,60% CPY-V O4 1,95% is stabilized with 2000 ppm of the compound of formula I-2.

Beispiel M9Example M9 Die nachfolgende LC-MischungThe following LC mixture

CC-3-V 36,50 % Klärpunkt [°C]: 75 CC-3-V1 2,00 % Δn [589 nm, 20 °C]: 0,1015 CCY-3-O1 8,00 % Δε [1 kHz, 20 °C]: -3,7 CCY-3-O2 6,00 % K1[pN, 20 °C]: 13,8 CCY-4-O2 2,50 % K3[pN, 20 °C]: 15,0 CLY-3-O2 8,00 % γ1 [mPa·s, 20 °C]: 97 CLY-3-O3 2,00 % V0 [20 °C, V]: 2,14 CPY-2-O2 10,00 % CPY-3-O2 3,00 % CY-3-O2 5,50 % PY-3-O2 13,00 % PY-1-O4 3,50 % wird mit 2000 ppm der Verbindung der Formel I-2 stabilisiert. CC-3-V 36.50% Clearing point [° C]: 75 CC-3-V1 2.00% Δn [589 nm, 20 ° C]: 0.1015 CCY-3-O1 8.00% Δε [1 kHz, 20 ° C]: -3.7 CCY-3-O2 6.00% K 1 [pN, 20 ° C]: 13.8 CCY-4-O2 2.50% K 3 [pN, 20 ° C]: 15.0 CLY-3-O2 8.00% γ 1 [mPa.s, 20 ° C]: 97 CLY-3-O3 2.00% V 0 [20 ° C, V]: 2.14 CPY-2-O2 10.00% CPY-3-O2 3.00% CY-3-O2 5.50% PY-3-O2 13.00% PY-1-O4 3.50% is stabilized with 2000 ppm of the compound of formula I-2.

Beispiel M10 (= Vergleichsbeispiel M9) Example M10 (= Comparative Example M9) Die nachfolgende LC-MischungThe following LC mixture

CC-3-V 31,50 % Klärpunkt [°C]: 75,5 PP-1-3 4,50 % Δn [589 nm, 20 °C]: 0,1086 CC-3-V1 3,30 % Δε [1 kHz, 20 °C]: -3,7 PY-3-O2 6,00 % K1[pN, 20 °C]: 12,9 PP-1-5 1,50 % K3[pN, 20 °C]: 15,2 PY-V2-O2 7,00 % γ1 [mPa·s, 20 °C]: 101 CEY-3-O2 3,70 % V0 [20 °C, V]: 2,14 CCY-V-O1 5,50 % CCY-V-O2 10,00 % CPY-V-O2 5,70 % CAIY-3-O2 7,00 % CCY-V-O4 7,40 CPY-V-O4 4,70 GPP-5-2 2,20 wird mit 2000 ppm der Verbindung der Formel I-1 stabilisiert. CC-3-V 31.50% Clearing point [° C]: 75.5 PP-1-3 4.50% Δn [589 nm, 20 ° C]: .1086 CC-3-V1 3.30% Δε [1 kHz, 20 ° C]: -3.7 PY-3-O2 6.00% K 1 [pN, 20 ° C]: 12.9 PP 1-5 1.50% K 3 [pN, 20 ° C]: 15.2 PY-V2-O2 7.00% γ 1 [mPa.s, 20 ° C]: 101 CEY-3-O2 3.70% V 0 [20 ° C, V]: 2.14 CCY-V O1 5.50% CCY-V O2 10.00% CPY-V O2 5.70% CAIY-3-O2 7.00% CCY-V O4 7.40 CPY-V O4 4.70 GPP 5-2 2.20 is stabilized with 2000 ppm of the compound of formula I-1.

Claims (15)

  1. Liquid-crystalline medium based on a mixture of polar compounds, characterised in that it comprises a compound of the formula I-1 and/or I-2
    Figure imgb0682
    where the proportion of compounds of the formula I-1 or of the formula I-2 in the mixture as a whole is 50 - 10000 ppm, based on the mixture,
    and
    additionally one or more compounds selected from the group of the compounds of the formulae IIA, IIB and IIC,
    Figure imgb0683
    Figure imgb0684
    Figure imgb0685
    in which
    R2A, R2B and R2C in each case, independently of one another, denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may be replaced by -O-, -S-,
    Figure imgb0686
    -C≡C-, -CF2O-, -OCF2-, -OC-O- or -O-CO- in such a way that O atoms are not linked directly to one another,
    L1-4 in each case, independently of one another, denote F, Cl, CF3 or CHF2,
    Z2 and Z2' in each case, independently of one another, denote a single bond, -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -COO-, -OCO-, -C2F4-, -CF=CF-, -CH=CHCH2O-,
    p denotes 0, 1 or 2,
    q denotes 0 or 1, and
    v denotes 1 to 6,
    and the medium additionally comprises one or more compounds selected from the group of the compounds of the formulae L-1 to L-11, the terphenyls of the formulae T-1 to T-21 and the compounds of the formulae BF-1 and BF-2,
    Figure imgb0687
    Figure imgb0688
    Figure imgb0689
    Figure imgb0690
    Figure imgb0691
    Figure imgb0692
    Figure imgb0693
    Figure imgb0694
    Figure imgb0695
    Figure imgb0696
    Figure imgb0697
    in which
    R, R1 and R2 in each case, independently of one another, have the meanings indicated for R2A and alkyl denotes an alkyl radical having 1-6 C atoms, and
    s denotes 1 or 2,
    Figure imgb0698
    Figure imgb0699
    Figure imgb0700
    Figure imgb0701
    Figure imgb0702
    Figure imgb0703
    Figure imgb0704
    Figure imgb0705
    Figure imgb0706
    Figure imgb0707
    Figure imgb0708
    Figure imgb0709
    Figure imgb0710
    Figure imgb0711
    Figure imgb0712
    Figure imgb0713
    Figure imgb0714
    Figure imgb0715
    Figure imgb0716
    Figure imgb0717
    Figure imgb0718
    in which
    R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms and
    m denotes 1-6,
    Figure imgb0719
    Figure imgb0720
    in which
    R1 and R2 in each case, independently of one another, have the meaning of R2A,
    c denotes 0, 1 or 2,
    d denotes 1 or 2.
  2. Liquid-crystalline medium according to Claim 1, characterised in that it comprises one or more compounds of the formulae
    Figure imgb0721
    Figure imgb0722
    Figure imgb0723
    Figure imgb0724
    Figure imgb0725
    Figure imgb0726
    Figure imgb0727
    Figure imgb0728
    Figure imgb0729
    Figure imgb0730
    Figure imgb0731
    Figure imgb0732
    Figure imgb0733
    Figure imgb0734
    Figure imgb0735
    Figure imgb0736
    Figure imgb0737
    Figure imgb0738
    Figure imgb0739
    Figure imgb0740
    Figure imgb0741
    Figure imgb0742
    Figure imgb0743
    Figure imgb0744
    Figure imgb0745
    Figure imgb0746
    Figure imgb0747
    Figure imgb0748
    Figure imgb0749
    Figure imgb0750
    Figure imgb0751
    Figure imgb0752
    Figure imgb0753
    Figure imgb0754
    Figure imgb0755
    Figure imgb0756
    Figure imgb0757
    Figure imgb0758
    Figure imgb0759
    Figure imgb0760
    Figure imgb0761
    Figure imgb0762
    Figure imgb0763
    Figure imgb0764
    Figure imgb0765
    Figure imgb0766
    Figure imgb0767
    Figure imgb0768
    Figure imgb0769
    Figure imgb0770
    Figure imgb0771
    Figure imgb0772
    Figure imgb0773
    Figure imgb0774
    Figure imgb0775
    Figure imgb0776
    Figure imgb0777
    Figure imgb0778
    Figure imgb0779
    Figure imgb0780
    Figure imgb0781
    Figure imgb0782
    Figure imgb0783
    Figure imgb0784
    Figure imgb0785
    Figure imgb0786
    Figure imgb0787
    Figure imgb0788
    Figure imgb0789
    in which alkyl and alkyl* in each case, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms and alkenyl denotes an alkenyl radical having 2-6 C atoms.
  3. Liquid-crystalline medium according to Claim 1 or 2, characterised in that the medium additionally comprises one or more compounds of the formula III,
    Figure imgb0790
    in which
    R31 and R32 in each case, independently of one another, denote a straight-chain alkyl, alkenyl, alkoxy, alkoxyalkyl or alkoxy radical having up to 12 C atoms, and
    Figure imgb0791
    Z3 denotes a single bond, -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -COO-, -OCO-, -C2F4-, -C4H9-, -CF=CF-.
  4. Liquid-crystalline medium according to one or more of Claims 1 to 3, characterised in that the medium additionally comprises one or more compounds of the formulae 0-1 to 0-18,
    Figure imgb0792
    Figure imgb0793
    Figure imgb0794
    Figure imgb0795
    Figure imgb0796
    Figure imgb0797
    Figure imgb0798
    Figure imgb0799
    Figure imgb0800
    Figure imgb0801
    Figure imgb0802
    Figure imgb0803
    Figure imgb0804
    Figure imgb0805
    Figure imgb0806
    Figure imgb0807
    Figure imgb0808
    Figure imgb0809
    in which
    R1 and R2 in each case, independently of one another, have the meanings indicated for R2A in Claim 1.
  5. Liquid-crystalline medium according to one or more of Claims 1 to 4, characterised in that the medium additionally comprises one or more compounds selected from the group of the compounds of the formulae O-6, O-7 and O-17,
    Figure imgb0810
    Figure imgb0811
    Figure imgb0812
    in which
    R1 denotes alkyl or alkenyl having 1-6 or 2-6 C atoms respectively and R2 denotes alkenyl having 2-6 C atoms.
  6. Liquid-crystalline medium according to one or more of Claims 1 to 5, characterised in that the medium additionally comprises one or more indane compounds of the formula In,
    Figure imgb0813
    in which
    R11, R12, R13 denote a straight-chain alkyl, alkoxy, alkoxyalkyl or alkenyl radical having 1-5 C atoms,
    R12 and R13 additionally also denote halogen,
    Figure imgb0814
    Figure imgb0815
    i denotes 0, 1 or 2.
  7. Liquid-crystalline medium according to one or more of Claims 1 to 6, characterised in that the medium additionally comprises at least one polymerisable compound.
  8. Liquid-crystalline medium according to one or more of Claims 1 to 7, characterised in that the medium additionally comprises one or more additives.
  9. Liquid-crystalline medium according to one or more of Claims 1 to 8, characterised in that the additive is selected from the group free-radical scavenger, antioxidant and/or stabiliser.
  10. Liquid-crystalline medium according to one or more of Claims 1 to 9, characterised in that the medium comprises one or more stabilisers selected from the group
    Figure imgb0816
    Figure imgb0817
    n = 1, 2, 3, 4, 5, 6 or 7
    Figure imgb0818
    n = 1, 2, 3, 4, 5, 6 or 7
    Figure imgb0819
    n = 1, 2, 3, 4, 5, 6 or 7
    Figure imgb0820
    Figure imgb0821
    Figure imgb0822
    Figure imgb0823
    Figure imgb0824
    Figure imgb0825
    Figure imgb0826
    Figure imgb0827
    Figure imgb0828
    Figure imgb0829
    Figure imgb0830
    Figure imgb0831
    Figure imgb0832
    Figure imgb0833
    Figure imgb0834
  11. Liquid-crystalline medium according to one or more of Claims 1 to 10, characterised in that the medium comprises one or more stabilisers in amounts of 0-10% by weight.
  12. Process for the preparation of a liquid-crystalline medium according to one or more of Claims 1 to 11, characterised in that the compound of the formula I-1 and/or the compound of the formula I-2 is mixed with at least one compound selected from the group of the compounds of the formulae IIA, IIB and IIC and additionally one or more compounds selected from the group of the compounds of the formulae L-1 to L-11, T-1 to T-21, BF-1 and BF-2 and with at least one further liquid-crystalline compound,
    and optionally one or more additives and optionally at least one polymerisable compound are added.
  13. Use of the liquid-crystalline medium according to one or more of Claims 1 to 11 in electro-optical displays.
  14. Electro-optical display having active-matrix addressing, characterised in that it comprises, as dielectric, a liquid-crystalline medium according to one or more of Claims 1 to 11.
  15. Electro-optical display according to Claim 14, characterised in that it is a VA, PSA, PA-VA, PS-VA, PALC, IPS, PS-IPS, FFS, UB-FFS or PS-FFS display.
EP15723433.7A 2014-05-27 2015-05-18 Liquid crystal medium Active EP3149110B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014007663 2014-05-27
PCT/EP2015/001011 WO2015180830A1 (en) 2014-05-27 2015-05-18 Liquid crystal medium

Publications (2)

Publication Number Publication Date
EP3149110A1 EP3149110A1 (en) 2017-04-05
EP3149110B1 true EP3149110B1 (en) 2019-12-11

Family

ID=53189773

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15723433.7A Active EP3149110B1 (en) 2014-05-27 2015-05-18 Liquid crystal medium

Country Status (7)

Country Link
EP (1) EP3149110B1 (en)
JP (1) JP2017517606A (en)
KR (1) KR20170012407A (en)
CN (1) CN106414666A (en)
DE (1) DE102015006246A1 (en)
TW (1) TWI668300B (en)
WO (1) WO2015180830A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2017195585A1 (en) * 2016-05-10 2018-05-24 Dic株式会社 Liquid crystal display element
JP2019077792A (en) * 2017-10-25 2019-05-23 Jnc株式会社 Liquid crystal composition and liquid crystal display element
CN111433324A (en) * 2017-12-08 2020-07-17 默克专利股份有限公司 liquid crystal medium
JP2020176255A (en) * 2019-04-18 2020-10-29 Jnc株式会社 Liquid crystal composition and liquid crystal display element

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795849A (en) 1972-02-26 1973-08-23 Merck Patent Gmbh MODIFIED NEMATIC PHASES
US3814700A (en) 1972-08-03 1974-06-04 Ibm Method for controllably varying the electrical properties of nematic liquids and dopants therefor
DE2450088A1 (en) 1974-10-22 1976-04-29 Merck Patent Gmbh Liquid crystalline dielectrics for electronic components - contg biphenylyl carboxylic acid phenyl ester or benzoic acid biphenylyl ester components
DE2637430A1 (en) 1976-08-20 1978-02-23 Merck Patent Gmbh Heterocyclic diaza cpd. in liquid crystalline dielectric - for electrooptical registration devices, giving stable orientation parallel to electrode surfaces
DE2853728A1 (en) 1978-12-13 1980-07-17 Merck Patent Gmbh LIQUID CRYSTALLINE CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF, ITS CONTAINING DIELECTRICS AND ELECTRO-OPTICAL DISPLAY ELEMENT
FR2595157B1 (en) 1986-02-28 1988-04-29 Commissariat Energie Atomique CELL WITH A DOUBLE LAYER OF LIQUID CRYSTAL, USING THE ELECTRICALLY CONTROLLED BIREFRINGENCE EFFECT AND METHOD FOR MANUFACTURING A UNIAXIC NEGATIVE ANISOTROPY ANISOTROPY MEDIUM FOR USE IN THIS CELL
JPH03255423A (en) * 1990-01-12 1991-11-14 Takiron Co Ltd Light control material
JPH08176549A (en) * 1994-12-22 1996-07-09 Matsushita Electric Ind Co Ltd Ultraviolet resistant liquid crystal material and liquid crystal display device
US6781665B2 (en) 2002-02-04 2004-08-24 Fujitsu Display Technologies Corporation Liquid crystal display and method of manufacturing the same
DE50306559D1 (en) 2002-07-06 2007-04-05 Merck Patent Gmbh Liquid crystalline medium
DE102004012970A1 (en) * 2003-04-11 2004-10-28 Merck Patent Gmbh Liquid crystalline media having high voltage holding ratio after UV and/or thermal stress, for use in electro-optical displays, containing bis-phenyl compound and UV-stabilizer
JP2005298733A (en) * 2004-04-14 2005-10-27 Chisso Corp Liquid crystal composition and liquid crystal display element
CN1989225B (en) * 2004-07-02 2012-07-11 默克专利股份有限公司 Liquid crystal medium and electro-optical display device containing same
JP4857543B2 (en) * 2004-10-29 2012-01-18 Dic株式会社 Nematic liquid crystal composition and liquid crystal display device using the same
WO2007017180A1 (en) * 2005-08-09 2007-02-15 Merck Patent Gmbh Liquid-crystal medium
JP5141947B2 (en) * 2007-06-29 2013-02-13 Dic株式会社 Nematic liquid crystal composition and liquid crystal display device using the same
CN101608120B (en) * 2008-07-08 2013-05-15 北京八亿时空液晶科技股份有限公司 A kind of nematic liquid crystal composition
DE102011013007A1 (en) * 2010-04-01 2011-10-06 Merck Patent Gmbh Liquid crystalline medium with a nematic phase and a negative dielectric anisotropy, useful in electro-optical displays or components, comprises a substituted cyclic compound and a compound comprising substituted piperidine structural unit
GB2565677B (en) * 2011-03-29 2019-05-15 Merck Patent Gmbh Liquid-crystalline medium
EP2722380B1 (en) * 2012-10-18 2018-02-21 Merck Patent GmbH Liquid crystal medium, method for the stabilisation thereof and liquid crystal display
EP2848676B1 (en) * 2013-09-12 2017-07-26 Merck Patent GmbH Liquid crystal medium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
DE102015006246A1 (en) 2015-12-03
JP2017517606A (en) 2017-06-29
TW201606058A (en) 2016-02-16
EP3149110A1 (en) 2017-04-05
CN106414666A (en) 2017-02-15
KR20170012407A (en) 2017-02-02
WO2015180830A1 (en) 2015-12-03
TWI668300B (en) 2019-08-11

Similar Documents

Publication Publication Date Title
EP2937401B1 (en) Liquid crystalline medium
EP2677019B1 (en) Liquid crystalline medium
EP3224331B1 (en) Liquid crystal medium
EP2534223B1 (en) Liquid crystalline medium
EP2957618B1 (en) Liquid crystalline medium
EP1958999B1 (en) Liquid crystalline medium
EP2176376B1 (en) Liquid-crystalline medium
EP2886627B1 (en) Liquid crystalline medium
EP1913114B1 (en) Liquid-crystal medium
EP2031040B1 (en) Liquid crystalline medium
EP2542647B1 (en) Liquid-crystalline medium
DE102019003615A1 (en) LIQUID CRYSTAL MEDIUM
DE102017002925A1 (en) Liquid crystalline medium
EP3149110B1 (en) Liquid crystal medium

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20161004

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180914

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190618

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAR Information related to intention to grant a patent recorded

Free format text: ORIGINAL CODE: EPIDOSNIGR71

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20191031

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1212176

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502015011201

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20191211

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200312

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200311

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200506

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200411

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502015011201

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

26N No opposition filed

Effective date: 20200914

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200531

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20200518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200518

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200518

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 1212176

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191211

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230518

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250423

Year of fee payment: 11